Introduction {#s1}
============

The human gut microbiome is known to play a crucial role in human energy harvest and homeostasis ([@bib2]; [@bib83]). Lean and obese people harbor different gut bacterial communities, suggesting that developing gut bacterial imbalances may contribute to obesity ([@bib47]; [@bib83]; [@bib82]). Importantly, transplantation of the fecal microbiota from obese humans to germ-free (GF) mice has been shown to result in the development of obesity-associated metabolic phenotypes in recipient mice ([@bib67]). These studies establish a causal relationship between gut bacteria and host metabolic status. The molecular mechanisms by which gut microbes regulate host metabolism, however, remain largely unknown. This lack of mechanistic understanding regarding the functions of microbial species and their metabolic capabilities has limited the effectiveness of both dietary and therapeutic approaches to improving host physiology ([@bib31]; [@bib85]).

The investigation of microbial metabolite production represents both an important opportunity and a challenge in the search to uncover the causal underpinnings of the effects of gut bacteria on host metabolism. One of the most concrete effects that human-associated bacteria have on the host is the production of small molecule metabolites, some of which accumulate to levels in the body higher than that of a typical drug ([@bib17]). Recent research suggests that bacterial metabolites play important roles in host metabolism by regulating host glucose and energy homeostasis ([@bib13]; [@bib25]; [@bib81]). The complexity of gut microbial ecosystems and associated microbial and host-derived microbial metabolites, however, presents significant obstacles on the path to defining how individual compounds elicit specific in vivo effects. Means to control specific metabolites is critical to understanding how these molecules affect host physiology. In this work, we selectively modulate the in vivo levels of bile acids and demonstrate that this controlled alteration of the metabolite pool exerts distinct effects on host physiology.

Bile acids are steroidal natural products that are synthesized from cholesterol in the liver and constitute an important part of the molecular environment of a healthy human gut ([@bib68]). Upon ingestion of a meal, bile acids are secreted from the liver and gallbladder into the duodenum where, with the activities of pancreatic enzymes, they form micelles that solubilize lipids and fat-soluble vitamins that are otherwise poorly absorbed. Remaining free bile acids are efficiently reabsorbed from the ileum via the action of bile acid transporters and recirculated back to the liver. Approximately 3--5% of bile acids escape enterohepatic recirculation and enter the colon at a rate of 400--800 mg/day, forming a concentrated pool of metabolites (200 to 1000 μM) ([@bib28]). In the colon, these molecules are modified by the resident bacteria in near-quantitative fashion, forming a class of on the order of 50 different metabolites called secondary bile acids ([Figure 1A](#fig1){ref-type="fig"}). In addition to their role in digestion, many primary and secondary bile acids act as ligands for host nuclear receptors, including the farnesoid X receptor (FXR), the pregnane X receptor (PXR), the vitamin D receptor (VDR), the liver X receptor (LXR) and the G-protein-coupled receptor TGR5 ([@bib21]; [@bib35]; [@bib54]; [@bib76]; [@bib78]). By acting as agonists or antagonists for these receptors, bile acids further impact the regulation of glucose tolerance and homeostasis, insulin sensitivity, lipid metabolism, triglyceride and cholesterol levels, and energy expenditure by the host ([@bib21]; [@bib59]). Additionally, bile acids regulate their own biosynthesis via an FXR-mediated negative feedback mechanism, which affects downstream nutrient availability for the host ([@bib59]). As a result of these interactions, bile acid imbalance has been implicated as having a causal effect in the development of diet-induced obesity ([@bib21]). Conversely, modification of the bile acid pool by commensal bacteria has been suggested to induce beneficial changes in host metabolism ([@bib34]).

![Enzymatic activity of gut bacterial bile salt hydrolase (BSH) enzymes.\
(**A**) BSH cleave the amide bond linking primary bile acids to taurine or glycine. (**B**) Structures of the two most abundant murine-conjugated bile acids, tauro-β-muricholic acid (TβMCA) and tauro-cholic acid (TCA).](elife-37182-fig1){#fig1}

The mechanisms underlying these effects, however, remain largely undefined. Due to the large number of compounds and receptors involved as well as the additional role of bile acids as biological detergents, the in vivo roles of specific bile acids have been difficult to untangle. Our novel approach to deconvoluting the physiological role of structurally distinct bile acids is to control the in vivo activity of selective bacterial bile salt hydrolases (BSH). BSH hydrolyze conjugated bile acids that have been linked to either taurine or glycine by host liver enzymes, revealing unconjugated bile acids ([Figure 1A](#fig1){ref-type="fig"}). This deconjugation step occurs prior to subsequent bacterial conversion of primary bile acids (e.g. cholic acid and chenodeoxycholic acid) to secondary bile acids (e.g. deoxycholic acid and lithocholic acid) ([@bib68]).

Prior work suggests that BSH play a critical role in regulating host metabolism. However, these studies have not yet uncovered how specific bile acid metabolites exert their in vivo effects on host metabolism, and conflicting results have been reported regarding whether BSH activity should be increased or decreased to achieve host metabolic benefits ([@bib34]; [@bib48]). Research efforts to date have either examined correlative relationships between BSH activities, bile acid levels, and metabolic indications ([@bib48]) or investigated the metabolic effects of 'unconjugated' versus 'conjugated' groups of bile acids ([@bib34]). It is imperative to be able to differentiate bile acids in vivo based on their structure in order to understand their effects on host metabolism. As an important example, taurocholic acid (TCA) and tauro-β-muricholic acid (TβMCA) are both conjugated bile acids but exert different physiological effects: TCA is an FXR agonist, while TβMCA is an FXR antagonist ([Figure 1B](#fig1){ref-type="fig"}) ([@bib48]; [@bib72]).

Herein, we uncover a group of bacteria within the abundant human gut commensal genus *Bacteroides* that possess selective BSH activity. We then identify the gene responsible for this activity in *Bacteroides thetaiotaomicron* and construct a knockout strain. By monocolonizing germ-free (GF) mice with the wild-type or BSH-deleted strain, we demonstrate that we can predictably alter the in vivo bile acid pool using this selective enzyme and that this change has significant effects on host metabolic status. Our results demonstrate that the deletion of a single bacterial gene can exert significant effects on host metabolism in a gnotobiotic environment and highlight the importance of modulating specific compounds when seeking to understand the effects of bacterial metabolites on host physiology.

Results {#s2}
=======

Selected species of *Bacteroides* accept distinct bile acid cores as BSH substrates {#s2-1}
-----------------------------------------------------------------------------------

BSH (EC 3.5.1.24) are found across a wide range of bacterial genera from the two dominant gut phyla, Bacteroidetes and Firmicutes ([@bib33]). However, the structural and activity characterization of these enzymes has been largely limited to Gram-positive species (i.e. *Clostridia*, *Lactobacillus*, *Bifidobacterium*, *Listeria*) ([@bib4]; [@bib70]). These enzymes largely demonstrate non-selective activities, cleaving all conjugated bile acids independent of either the bile acid core or amino acid conjugate (taurine or glycine) ([@bib68]). While differential reactivity toward conjugated substrates has been observed in some Gram-positive strains, in these cases, the selectivity has been based on a preference for one amino acid over the other, not on the structure of the steroidal core ([@bib12]; [@bib26]; [@bib38]; [@bib68]). In contrast, the activity of Gram-negative bacteria has been largely underexplored. While *Bacteroides fragilis* ATCC 25285 was reported to exhibit non-selective BSH activity ([@bib79]), some *Bacteroides vulgatus* strains were observed to cleave taurochenodeoxycholic acid (TCDCA) and TβMCA but minimally cleaved TCA ([@bib9]; [@bib36]), thus exhibiting a degree of selectivity based on the hydroxylation pattern of the steroid. These results suggested to us that perhaps other strains within the phylum Bacteroidetes might display steroidal core-based selectivity. To investigate this question, we performed a screen of the BSH activity of twenty Bacteroidetes strains found in the human gut ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}) ([@bib44]). We also tested *Clostridium perfringens* and *Lactobacillus plantarum*, two Gram-positive species with known non-selective BSH activities, for comparison. We incubated pre-log phase cultures of individual strains with a group of either the most abundant tauro- or the most abundant glyco-conjugated bile acids found in the human and murine GI tracts. We monitored deconjugation over time by UPLC-MS and determined that all hydrolysis reactions had reached steady state by 48 hr ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). We then quenched the cultures and profiled bacterial bile acid metabolism. As expected, *C. perfringens* ATCC 13124, *L. plantarum* WCFS1, and *B. fragilis* ATCC 25285 deconjugated all conjugated bile acid substrates tested. Strikingly, the majority of Bacteroidetes strains tested displayed some degree of selectivity for conjugated bile acid substrates, with a preference for deconjugating tauro- over glyco-conjugated substrates. A subset of these strains (*B. thetaiotaomicron* VPI-5482, *B. caccae* ATCC 43185, *B. fragilis* 638R, *Bacteroides* sp. D2, and *Bacteroides* sp. 2_1\_16; Group I -- red, [Figure 2A](#fig2){ref-type="fig"}) exhibited selectivity exclusively based on the steroidal core structure, deconjugating C12 = H primary bile acids (i.e. TCDCA, GCDCA, and TβMCA) but not C12 = OH primary bile acids (i.e. TCA and GCA).

![Identification of selective BSH activity in the human gut bacterial phylum Bacteroidetes.\
(**A**) Deconjugation ability of twenty prevalent Bacteroidetes strains and two Firmicutes strains found in the human gut represented as heat maps. Individual strains were incubated for 48 hr total with a group of glyco- or tauro-conjugated bile acids found in human and murine GI tracts. G (glyco-), T (tauro-), CA (cholic acid), CDCA (chenodeoxycholic acid), UDCA (ursodeoxycholic acid), DCA (deoxycholic acid), LCA (lithocholic acid), βMCA (β-muricholic acid). Assays were performed in biological duplicate. Group I (red): Bacteroidetes species that deconjugate primary bile acids based on steroidal core structure (C12 = H but not C12 = OH); Group II (gray): species that deconjugate based on amino acid conjugate; Group III (blue): species that deconjugate all bile acid substrates; Group IV (black): no deconjugation observed. (**B**) Representative UPLC-MS timecourses for deconjugation of TDCA and TLCA showing that steady state has been reached by 48 hr. (**C**) Representative UPLC-MS traces showing that *Bacteroides thetaiotaomicron* wild-type (Bt WT) and BtΔ1259 deconjugate TUDCA, whereas BtΔ2086 does not. BtΔ2086,2086 + recovered the deconjugation function while the BtΔ2086,CTRL +control strain containing an empty pNBU2 vector did not, demonstrating that BT2086 is responsible for bile salt hydrolase activity in Bt. (**D**) Representative UPLC-MS traces showing that Bt WT deconjugates the murine primary bile acid TβMCA but not TCA, whereas BTΔ2086 (Bt KO) does not deconjugate either bile acid.](elife-37182-fig2){#fig2}

To our knowledge, this study represents the first systematic evaluation of BSH activity in the common gut-bacterial phylum Bacteroidetes. Given that specific conjugated and unconjugated bile acids bind to different host receptors and have the potential to exert different downstream effects, the selectivity uncovered here may have important physiological consequences depending on which *Bacteroides* species colonize the host. To further explore this possibility and define the effects of selective BSH on host physiology, we monocolonized GF mice with isogenic strains of wild-type and BSH-deleted *B. thetaiotaomicron* as described below.

BT2086 is responsible for BSH activity in *B. thetaiotaomicron* {#s2-2}
---------------------------------------------------------------

We recognized that deletion of the BSH enzyme from one of the Group I *Bacteroides* species would provide us with a paired set of isogenic strains (wild-type and knockout) that would allow us to rationally manipulate the in vivo bile acid pool in a highly specific manner. In mice, the two most abundant primary bile acids are TCA and TβMCA ([@bib72]). Based on the observed selectivity for deconjugating C12 = H but not C12 = OH core primary bile acids, we predicted that colonization with a BSH wild-type strain would result in lower levels of TβMCA (C12 = H) relative to knockout colonized mice, while the levels of TCA (C12 = OH) in both groups would remain constant. All the five Group I strains displayed weak-to-moderate deconjugation of TβMCA in vitro ([Figure 2A](#fig2){ref-type="fig"}). Importantly, we did not detect any products of TCA deconjugation from any of these strains. This result suggested that the levels of deconjugated CA in mice colonized with these bacteria would remain low to undetectable, while the levels of deconjugated βMCA could build up due to enterohepatic recirculation. We decided to focus our efforts on generating paired isogenic strains in one of these species, *B. thetaiotaomicron* (Bt). Although this strain displayed relatively weak TβMCA-deconjugating activity, Bt had been previously shown to be amenable to genetic manipulation, allowing knockout of putative BSH genes ([@bib10]; [@bib43]).

We performed a BLASTP search of the characterized BSH from *C. perfringens* ([@bib68]) against the Bt genome and identified two genes, BT2086 and BT1259, as putative BSH. We constructed unmarked deletions of these genes using allelic exchange and then tested the resultant mutants for their ability to deconjugate bile acids in whole cell culture using UPLC-MS. The BtΔ2086 mutant (henceforth referred to as Bt KO) had lost the ability to cleave conjugated bile acid substrates. In contrast, the BtΔ1259 mutant displayed no loss-of-function phenotype ([Figure 2C](#fig2){ref-type="fig"}). Complementation of the Bt KO strain with BT2086 restored BSH activity ([Figure 2C](#fig2){ref-type="fig"}), confirming that BT2086 is necessary for bile acid deconjugation in Bt. Since bile salt hydrolases and penicillin V amidases (PVA) both belong to the cholylglycine hydrolase (CGH) family and share a high degree of sequence homology, it is possible that BT1259 is a PVA, although additional experiments would be needed to definitively establish this activity ([@bib33]; [@bib63]). Finally, we verified that when incubated with both TβMCA and TCA, Bt wild-type (Bt WT) deconjugated TβMCA but not TCA, whereas the Bt KO strain did not deconjugate either bile acid ([Figure 2D](#fig2){ref-type="fig"}).

Bacteroidetes BSH exhibit evolutionary diversity {#s2-3}
------------------------------------------------

A phylogenetic grouping of the 20 Bacteroidetes strains assayed revealed that while the species that deconjugate bile acids based on the amino acid conjugate (Group II -- gray, [Figure 2A](#fig2){ref-type="fig"}) form a partial clade ([Figure 3A](#fig3){ref-type="fig"}), the strains that exhibit selectivity based on the steroid core (Group I -- red) and those that display no selectivity (Group III -- blue) are not separated into distinct clades. A BLAST-P search using BT2086 as a query gene identified candidate BSH genes in 19 of the 20 Bacteroidetes strains tested. *Bacteroides finegoldii* DSM 17565 did not display BSH activity and also lacked a putative BSH. A phylogenetic tree resulting from the multiple sequence alignment of these 19 candidate BSH genes revealed a lack of homology among enzymes within a given activity group ([Figure 3B](#fig3){ref-type="fig"}). Group II enzymes, which had formed a clade at the strain level, are now separated into two groups, and steroid core-selective strains (Group I) do not cluster significantly. Taken together, these findings suggest that preference for C12 = H over C12 = OH primary bile acid cores is an activity that may have evolved multiple times independently from related members of the BSH superfamily.

![Homology-based classification of Bacteroidetes strains and putative BSH genes.\
(**A**) Phylogenetic tree of 20 Bacteroidetes strains using alignment-based whole proteome phylogeny (PhyloPhlAn). Bacteroidetes strains from Group II (gray; deconjugation based on amino acid) form a partial clade, while Group I (red) and Group III (blue) strains do not separate into distinct clades. (**B**) Phlyogenetic tree of candidate Bacteroidetes BSH genes. A search for BLAST-P matches of BT2086 identified an ortholog in 19 of the 20 Bacteroidetes species assayed. Numbers next to the branches represent the percentage of replicate trees in which this topology was reached in a bootstrap test of 1000 replicates. No significant clustering of Bacteroidetes strains into clades based on enzymatic activity was observed. Scale bars represent number of nucleotide substitutions per site.](elife-37182-fig3){#fig3}

Genetic removal of Bt BSH results in specific changes to murine bile acid pools in vivo {#s2-4}
---------------------------------------------------------------------------------------

To test our hypothesis that deleting a single bacterial gene, the bile salt hydrolase BT2086, would result in a predictable and selective alteration of the in vivo bile acid pools, GF mice were monocolonized with Bt WT or Bt KO (monocolonization experiment, [Figure 4A](#fig4){ref-type="fig"}). To further assess effects of this single microbial gene on overall host metabolism and energy utilization, we also performed an experiment in CLAMS (Comprehensive Lab Animal Monitoring System) cages using three groups of animals: (1) mice monoassociated with Bt WT, (2) mice monoassociated with Bt KO or (3) GF control mice which remained sterile (CLAMS experiment, [Figure 4A](#fig4){ref-type="fig"}). For both studies, over a 4-week period, mice were fed a high-fat, high-sugar diet designed to mimic a Western-style human diet (60% kcal% fat). For the last week of the CLAMS experiment, mice were transferred from gnotobiotic isolators to pre-sterilized metabolic cages with continuous monitoring in the CLAMS system in order to carefully monitor metabolic status.

![Monocolonization of GF mice with BT WT and Bt KO results in predictably altered bile acid pools.\
(**A**) Male germ-free C57BL/6 mice were monocolonized with either Bt WT or BT KO and fed a high-fat diet (HFD) for 4 weeks (monocolonization experiment). In a second experiment, monocolonized mice (Bt WT or Bt KO) or GF mice were fed a HFD for 4 weeks and transferred to CLAMS during the 4th week to monitor metabolic inputs and outputs (CLAMS experiment). (**B**) Bile acid profiling using UPLC-MS revealed that Bt KO-colonized mice displayed higher levels of TβMCA in cecal contents than Bt WT-colonized mice while the levels of TCA remained the same between the two groups. βMCA levels were significantly higher in Bt WT-colonized animals and no CA was detected in any group (red boxes). (**C--D**) Similar changes were observed in feces (**C**) and distal ileum (**D**), although no βMCA was observed in any group in the distal ileum. Data are presented as mean ± SEM. BA (bile acid). For the monocolonization experiment, n = 12 mice per group, Welch's t test. For the CLAMS experiment, n = 7--8 mice per group, one-way ANOVA followed by Tukey's multiple comparisons test. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001.](elife-37182-fig4){#fig4}

We first confirmed that BT2086 was expressed in vivo by performing qRT-PCR on cecal contents from Bt WT-colonized mice ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). As expected, no BT2086 transcripts were detected in the cecal contents of BT KO-colonized mice. We then performed bile acid analyses on tissues and blood from mice in both experiments. As we predicted, Bt KO-colonized mice displayed higher levels of TβMCA in cecal contents than Bt WT-colonized mice in the monocolonization experiment ([Figure 4B](#fig4){ref-type="fig"}). Bt KO-colonized mice also exhibited significantly lower levels of βMCA (p\<0.0001), the product of TβMCA hydrolysis, than Bt WT-colonized mice. Importantly, the levels of TCA remained unchanged between the two groups, and no CA was detected in either group. These results are consistent with our in vitro data showing that the Bt BSH can deconjugate C12 = H but not C12 = OH primary bile acids. We observed the same significant difference in βMCA levels in feces ([Figure 4C](#fig4){ref-type="fig"}, red highlight boxes). In the CLAMS experiment, in agreement with previous reports ([@bib72]), GF mice had significantly higher overall bile acid levels than colonized mice (p=0.0012 Bt WT vs GF, p=0.0071 BT KO vs GF). Consistent with the monocolonization experiment, cecal contents of Bt KO-colonized mice displayed significantly lower levels of βMCA (p\<0.0001, Bt WT vs GF and BT KO vs GF) than cecal contents of Bt WT-colonized mice, while CA remained undetectable in both groups ([Figure 4B](#fig4){ref-type="fig"}).

We also profiled the bile acid composition in the distal ileum, the site of active bile acid reuptake from the small intestine, in the CLAMS experiment. As expected, the bile acid concentrations were approximately fivefold higher in this compartment than in cecal and fecal contents ([Figure 4D](#fig4){ref-type="fig"}) ([@bib72]). We observed the same trend as we had noted in cecal contents, with higher TβMCA levels in Bt KO-colonized mice, although the differences were not statistically significant (p=0.9343). During sacrifice, we noted that the distribution of this food debris was not uniform along the length of the small intestine. This heterogeneity of contents in the distal ileum may help explain the large range of bile acid measurements observed in this compartment.

In contrast to the cecum, feces, and distal ileum, the liver and circulating plasma ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) of Bt WT- and Bt KO-colonized mice contained similar bile acid compositions, with no significant differences noted. These data are consistent with previous observations that the greatest differences between GF and conventionally raised mice were in the cecum and colon, not in the liver or the blood ([@bib72]). We also observed a significant upregulation of bile acid synthesis genes in the liver (vide infra), suggesting that de novo bile acid synthesis may lessen the observed differences between the two groups.

Taken together, our data show that we can rationally manipulate the in vivo bile acid pool in the cecum and to a lesser extent in the small intestine and distal colon (i.e. feces) using a *Bacteroides* BSH enzyme that selectively cleaves C12 = H but not C12 = OH conjugated primary bile acids. Importantly, this selective hydrolysis allows us to modulate the levels of TβMCA, a known FXR antagonist, while leaving the levels of TCA, an FXR agonist unchanged.

Bt BSH status affects host metabolic indications {#s2-5}
------------------------------------------------

Having shown that Bt BSH status selectively determines composition of the bile acid pool in monocolonized GF mice, we next sought to explore how these specific changes in bile acid levels affected host metabolism. Strikingly, Bt KO-colonized mice gained less weight on the high-fat diet than Bt WT-colonized mice in the monocolonization experiment ([Figure 5A](#fig5){ref-type="fig"}). This result is notable because it has been shown that GF mice are more resistant to weight gain when fed a high-fat diet ([@bib3]). In addition, we performed a relatively short diet intervention compared to other studies that have used HFD to study metabolic changes ([@bib32]; [@bib34]; [@bib65]; [@bib74]), and we did not expect to observe significant changes in body weight over the course of a shorter experiment. Importantly, the host effects observed are not due to differences in colonization efficiency. In both experiments, Bt WT and Bt KO efficiently colonized the GI tract and remained the only bacterial species in the mono-associated animals ([Figure 5B](#fig5){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These data suggest that the observed metabolic changes are rather due to alterations in the bile acid pool driven by the presence or absence of the Bt BSH.

![Bt BSH colonization status affects weight gain and lipid profiles.\
(**A**) Weight-matched, male, germ-free C57BL/6 mice monocolonized with Bt KO gained less weight during a 4-week diet challenge than Bt WT-colonized mice. n = 12 mice per group, multiple t test analysis using the FDR method (Q = 1%), \*\*\*p\<0.001 (FDR-corrected). (**B**) Microbial biomass did not differ between the Bt WT and Bt KO strains in GF mice. For the monocolonization experiment, frozen feces (day 2 post-colonization) were plated to determine colony-forming units per gram. For the CLAMS experiment, fresh feces (day 2) were plated. Cecal contents collected at sacrifice (day 32) were also plated to confirm maintenance of monocolonized status throughout the experiment. No CFU were detected in the GF group. n = 6 samples per group, Mann-Whitney test. (**C--D**) Lipid levels in plasma and blood, monocolonization experiment. (**C**) Triglyceride, free fatty acid, and cholesterol levels were lower in the plasma of Bt KO-colonized mice. (**D**) Levels of triglycerides were reduced in Bt KO-colonized mice. No significant differences in liver free fatty acids, liver cholesterol, or liver cholesterol esters were observed. n = 12 mice per group, Welch's t test. (**E**) Representative H and E staining of liver sections (monocolonization experiment). Bt KO-colonized mice displayed decreased liver steatosis. Scale bars, 100 μm. Yellow arrows indicate representative white lipid droplets. n = 4 mice per group. All data are presented as mean ± SEM. \*p\<0.05, \*\*p\<0.01.](elife-37182-fig5){#fig5}

Consistent with the reduced weight gain phenotype, we observed lower levels of triglycerides, cholesterol, and free fatty acids in plasma ([Figure 5C](#fig5){ref-type="fig"}) as well as lower triglyceride levels in liver ([Figure 5D](#fig5){ref-type="fig"}) of Bt KO-colonized compared to Bt WT-colonized mice in the monocolonization experiment. Bt KO-colonized mice also exhibited less liver steatosis than Bt WT-colonized mice, consistent with the lower liver triglyceride levels in the former group ([Figure 5E](#fig5){ref-type="fig"}).

In order to further investigate the effects of Bt BSH status on host metabolism, we transferred Bt KO- or Bt WT-colonized or GF mice to metabolic cages (CLAMS experiment). After a 24 hr acclimation period, we monitored metabolic inputs and outputs for 6 days. We observed significant metabolic differences between the three groups of mice. Both Bt KO-colonized mice and GF mice displayed a lower respiratory exchange ratio (RER) than Bt WT-colonized mice ([Figure 6A](#fig6){ref-type="fig"}). RER is calculated as the ratio of carbon dioxide produced to oxygen consumed and is used as a measurement of the relative utilization of carbohydrates versus lipids as an energy source (carbohydrate utilization RER = 1, lipid RER = 0.7). Thus, our data indicate that both the Bt KO-colonized and GF mice are utilizing more lipids for energy than carbohydrates relative to the Bt WT-colonized mice. While Bt KO-colonized mice consumed more oxygen than Bt WT-colonized mice ([Figure 6B](#fig6){ref-type="fig"}), there were no significant differences in carbon dioxide production between groups (full day, Bt WT vs Bt KO p=0.4041; Bt WT vs GF p=0.3239; Bt KO vs GF p=0.0606) ([Figure 6C](#fig6){ref-type="fig"}). These data are consistent with the lower RER observed in Bt KO-colonized mice. No statistically significant differences in locomotor activity were noted between the three groups ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We then used linear regression to investigate the relationship between metabolic rate and body weight in the three groups of mice. Conventionally raised mice as well as humans display a positive linear correlation between energy expenditure and body mass ([@bib23]; [@bib60]). While Bt WT-colonized mice displayed this linear relationship (p=0.0168, R^2^ = 0.7134), strikingly, both Bt KO-colonized (p=0.6806, R^2^ = 0.03017) and GF (p=0.6930, R^2^ = 0.02782) mice did not ([Figure 6D](#fig6){ref-type="fig"}). These data suggest that the deletion of a single bacterial gene, a selective bile salt hydrolase, results in loss of the relationship between metabolic rate and body weight in the host. Taken together, our data from both the monocolonized experiment and the CLAMS experiment suggest that the Bt KO-colonized mice exhibit a metabolic phenotype distinct from Bt WT-colonized mice.

![Bt WT-colonized, Bt KO-colonized, and GF mice display distinct metabolic phenotypes.\
Mice were monitored in metabolic cages during the final week of the CLAMS experiment and continued on a HFD. Mice were allowed to acclimate to cages for 24 hr prior to the start of data acquisition. (**A**) Respiratory exchange ratio (RER). One-way ANOVA followed by Tukey's multiple comparisons test, \*p\<0.05. (**B--C**) Oxygen consumption and (**B**) carbon dioxide production (**C**). ANCOVA with lean body mass as the covariate, \*p\<0.05. (**D**) Regression plot of energy expenditure as a function of lean mass. Energy expenditure (EE) is given by EE = CV x VO2, where CV = 3.815 + 1.232(RER). For the Bt WT-colonized group, \*p=0.0168, indicating the slope is significantly non-zero. For the Bt KO-colonized and GF groups, p=0.6806 and p=0.6930, respectively. For (**A--C**), data are represented as mean ± SEM, where the number of samples is the number of mice. For Bt WT-colonized group, n = 7 mice, and for Bt KO-colonized and GF groups, n = 8 mice per group.](elife-37182-fig6){#fig6}

Distal ileum bile acid pools exhibit similar detergent properties {#s2-6}
-----------------------------------------------------------------

The reduced respiratory exchange ratio and weight gain of Bt KO-colonized mice suggest a reduced energy availability profile that is consistent with either reduced food consumption or less efficient caloric extraction from food. In the monocolonization experiment, Bt KO-colonized mice consumed less food during HFD feeding than Bt WT-colonized mice (−2.28 g ± 1.36 g vs. +3.39 g±1.61 g per cage per week, respectively, compared to weekly average for all cages, p=0.0165). This result indicates that decreased caloric intake may be a contributing factor in the former group's decreased weight gain. Since bile acids act as biological detergents that aid in digestion, it is conceivable that the differences in bile acid pools between the groups could alter caloric extraction efficiency. To test this hypothesis, we performed a detergent assay in which we determined the ability of the bile acid pools to solubilize a mixture of fats representative of lipolysis products in the small intestine ([@bib30]). Bile acid pools for Bt KO- and Bt WT-colonized mice were reconstituted using the mean values for individual compounds measured in the distal ileum and incubated with a 1:1:1 mixture of oleic acid, sodium oleate and 1-oleoyl-*rac*-glycerol under conditions representative of those in the small intestine (150 mM NaCl, pH 6.3, 37˚C) ([@bib30]). Sodium dodecyl sulfate (SDS) was used as a positive control at its critical micelle concentration (8.2 mM). At both 5 hr and 24 hr time points, we did not detect any differences in solubilization at four different fat concentrations as measured by the turbidity of the resulting mixtures ([Figure 7A](#fig7){ref-type="fig"}). Taken together, these data suggest that the metabolic differences observed between the Bt WT- and Bt KO-colonized mice are not due to different detergent abilities of the bile acid pools. In further support of this conclusion, fecal bomb calorimetry did not reveal any differences in energy remaining in fecal pellets from Bt WT-colonized, Bt KO-colonized, or GF mice, indicating that there were no notable differences in caloric energy extraction from food between these groups ([Figure 7B](#fig7){ref-type="fig"}). These data suggest that the observed metabolic differences between Bt WT- and Bt KO-colonized mice may be due to differences in bile acids acting as signaling molecules in the host.

![Detergent properties of ileal bile acid pools do not significantly differ.\
(**A**) Bile acid pools were reconstituted in vitro using the mean values measured from the distal ileum of Bt KO- and Bt WT-colonized mice (CLAMS experiment). Pools were added to four different concentrations of a mixture of fats representative of lipolysis products in the small intestine and incubated under physiologically relevant conditions (37˚C, pH 6.3). SDS (sodium dodecyl sulfate) was used as a positive control at its critical micelle concentration (8.2 mM). No significant differences in solubilization effects as measured by OD400 were observed at 5 hr and 24 hr time points. n = 3 biological replicates per condition, one-way ANOVA followed by Tukey's multiple comparisons test. (**B**) No significant differences were observed in energy content of feces collected from Bt KO-colonized, Bt WT-colonized, or GF mice (CLAMS experiment). Feces were collected from CLAMS cages. n = 7--8 mice per group, one-way ANOVA followed by Tukey's multiple comparisons test. Each data point represents the mean of two calorimetry experiments per mouse. All data are presented as mean ± SEM.](elife-37182-fig7){#fig7}

Bt BSH status affects host global transcriptional response {#s2-7}
----------------------------------------------------------

In order to investigate the gene regulatory mechanisms underlying the metabolic changes observed in Bt KO- compared to Bt WT-colonized mice, we performed RNA-sequencing (RNA-Seq) on distal ileum from the monocolonization experiment ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). We decided to focus our analysis on the distal ileum for three reasons. First, while known bile acid receptors are highly expressed in both liver and intestinal tissue, we observed larger differences in bile acid pool composition in the GI tract (i.e. small intestine, cecum, feces) than the liver and blood, suggesting that differences in bile-acid-mediated signaling effects will likely be greater in the small intestine than in the liver. Second, bile acid concentrations are significantly higher in the small intestine than the cecum and colon, the other sites at which we observed differences in bile acid pool composition (approximately 5-fold and 100-fold higher, respectively) ([@bib72]). Third, following passage through the small intestine, bile acids are absorbed and recirculated back to the liver primarily in the distal ileum ([@bib11]), making this site the nexus for bile acid sensing and transport in the GI tract.

Global transcriptional analysis of the distal ileum identified 12,432 genes, of which 428 genes were differentially expressed (adjusted FDR ≤ 0.05, fold-change ≥±1.5) between the Bt KO- and Bt WT-colonized mice. Of those genes, the majority (314 genes) were increased in the Bt KO-colonized mice ([Figure 8A](#fig8){ref-type="fig"}). Multidimensional scaling analysis (MDS) revealed that the two monocolonized groups segregate based on their transcriptional profiles ([Figure 8B](#fig8){ref-type="fig"}). Gene Ontology (GO) and KEGG pathway analyses of RNA-Seq expression data revealed coordinated changes in gene expression related to metabolism, circadian rhythm, immune response, and histone modifications ([Figure 8C](#fig8){ref-type="fig"}).

![Global transcription analysis revealed changes in metabolism, circadian rhythm, immune response, and histone modification pathways in the distal ileum of Bt KO- vs.\
Bt WT-colonized mice (monocolonization experiment). (**A**) Log2-transformed fold change in normalized RNA-seq gene counts in the distal ileum of GF mice colonized with Bt KO relative to mice colonized with Bt WT. MA plot showing the relationship between average concentration (logCPM) and fold-change (logFC) across the genes. Each gene is represented by a black dot. Significant differentially expressed genes are colored in red. The blue lines represent logFC ±0.5 threshold. (**B**) Multidimensional scaling (MDS) plot of two monocolonized groups (S1-S6: Bt WT-colonized mice; S7-S12: Bt KO-colonized mice) derived from RNA-Seq normalized gene counts, showing that samples segregate based on colonization status (Bt WT vs. Bt KO). (**C**) Changes in the host distal ileum transcriptome between Bt WT- and Bt KO-colonized conditions. Heatmap shows statistically significant fold changes of genes identified using differential expression analysis (FDR ≤ 0.05 and absolute Log2 fold-change ≥0.5). n = 6 samples for each group. (**D--E**) Gene expression in the distal ileum as measured by qPCR. Data are presented as mean ± SEM; n = 12 mice/group; \*p\<0.05, Welch's t test.](elife-37182-fig8){#fig8}

The largest group of differentially expressed genes were those related to host metabolism. We observed significant changes in genes related to carbohydrate and lipid metabolism, amino acid degradation and nitrogen metabolism, and xenobiotic metabolism. In particular, genes involved in the transport (*Slc2a1*) and breakdown (*Hk1/2*, *Pfkl/m*) of glucose were upregulated, whereas *G6pc* (glucose-6-phosphatase), the final enzyme in the gluconeogenesis pathway, was significantly downregulated (8.8-fold), indicating a shift away from gluconeogenesis and toward glycolysis in the distal ileum of Bt KO-colonized mice. We confirmed the transcriptional change of *G6pc* in distal ileum using qPCR ([Figure 8D](#fig8){ref-type="fig"}). Consistent with these findings, we observed significantly higher blood glucose levels in Bt KO-colonized mice compared to Bt WT-colonized mice in the CLAMS experiment (p=0.0228), indicating an increase in glucose available for glycolysis in the distal ileum ([Figure 9A](#fig9){ref-type="fig"}).

![Bt BSH status affects transcription of genes in FXR-dependent and FXR-independent pathways.\
(**A**) Plasma glucose and hormone levels, CLAMS experiment. Mice were fasted for 4 hr prior to terminal blood draw. n = 7--8 mice per group, data are presented as mean ± SEM, one-way ANOVA followed by Tukey's multiple comparisons test, \*p\<0.05, \*\*p\<0.01. (**B**) Expression of genes in FXR-mediated pathways in the distal ileum was not significantly different between Bt KO- and Bt WT-colonized mice as measured by qPCR. (**C**) Gene expression in the liver as measured by qPCR. Genes in both FXR-mediated pathways (*Nr0b2*/*Shp*, *Cyp7a1*, *Apoc2*) and pathways not known to be mediated by FXR (*Cd36*, *Tnf*/*Tnfα*, *Adgre1*/*Emr1*, *Sphk2*) were significantly affected by Bt BSH status. (**B--C**) Data are presented as mean ± SEM; n = 12 mice/group; \*p\<0.05, \*\*p\<0.001, ns - not significant, Welch's t test.](elife-37182-fig9){#fig9}

The expression pattern for genes related to lipid metabolism was more complex, with pathways related to both lipogenesis and lipid breakdown upregulated in Bt KO-colonized animals. Two key genes in the ketogenesis pathway, *Bdh1* (3-hydroxybutyrate dehydrogenase 1) and *Hmgcs2* (3-hydroxy-3-methylglutaryl-CoA synthase 2), were significantly upregulated ([Figure 8C](#fig8){ref-type="fig"}), indicating an increase in the use of lipid and ketogenic amino acid degradation for energy production in the host. Additional genes related to amino acid degradation (*Hao2*, *Nos1*, *Pcca*, *Tat*) were also significantly upregulated. Expression of genes involved in the biosynthesis of both glycerophospholipids, in particular phosphatidic acid (*Dgkg*, *Dgkh*, *Gpam*, *Mboat1*, *Mboat2*), and sphingolipids, in particular cerebrosides and gangliosides (*Glb1*, *St3gal5*, *St6galnac6*, *Ugt8a*), was also higher in KO-colonized mice. Complex fats synthesized via de novo lipogenesis serve as ligands for PPAR type II nuclear receptors ([@bib52]). RNA-Seq data revealed that *Pparg* expression was significantly up-regulated in Bt KO-colonized mice ([Figure 8C](#fig8){ref-type="fig"}). Activation of *Pparg* has been shown to both enhance glucose metabolism and increase lipid uptake ([@bib56]), consistent with our broader transcriptional analysis. We confirmed that *Pparg* expression was significantly upregulated in KO-colonized animals by qPCR (p=0.0207) ([Figure 8D](#fig8){ref-type="fig"}). Collectively, these data suggest that ileal cells in KO-colonized mice have shifted toward a regime of enhanced glycolysis and increased lipid uptake for the purposes of both the synthesis of complex fats and the breakdown of lipids for energy.

Transcriptional analysis also revealed changes in genes regulating circadian rhythm. The observed inverse relationship between expression of the transcriptional activators (*Npas2* and *Arntl,* decreased in Bt KO-colonized mice) and circadian repressors (*Per1*, *Per2*, *Per3*, *Cry2*, increased in Bt KO-colonized mice) is consistent with the transcription-translation negative feedback loop that establishes diurnal rhythms ([@bib39]). The relative changes in circadian rhythm regulation genes were validated using qPCR ([Figure 8E](#fig8){ref-type="fig"}). These data indicate that tissues in the distal ileum of Bt KO-colonized mice exist in an altered circadian synchronization state compared to those of Bt WT-colonized mice. Genes involved in immune homeostasis and histone modifications were also differentially expressed. Of particular note, Toll-like receptors (*Tlr1*, *Tlr2*, *Tlr4*), innate immune receptors that play key roles in recognizing microbially produced molecules ([@bib1]), were significantly upregulated in our Bt KO-colonized mice. Taken together, these data suggest that bile acid pool alteration elicited a broader scope of changes in the host beyond those directly related to energy production and lipid synthesis.

Bile acid pools alter the expression of FXR-dependent and FXR-independent genes in the liver and distal ileum {#s2-8}
-------------------------------------------------------------------------------------------------------------

We next sought to investigate the hypothesis that the two bile acid pools would differentially and predictably affect FXR signaling in the small intestine and the liver. Prior work has shown that the gut microbiome mainly affects FXR targets in the ileum but not the liver ([@bib72]). Specifically, activation of ileal FXR leads to production of fibroblast growth factor 15/19 (FGF15 in mice and FGF19 in humans). FGF15 then translocates to the liver where it binds to the FGFR4/β-Klotho complex and represses the expression of *Cyp7a1*, which encodes an enzyme catalyzing the rate-limiting step in bile acid synthesis from cholesterol ([@bib15]). In this way, activation of FXR in the ileum downregulates bile acid synthesis in the liver. In our system, the levels of the FXR antagonist TβMCA were higher in the cecal contents of Bt KO- versus Bt WT-colonized mice, while the levels of the FXR agonist TCA remain constant between these two groups. Based on these results, we predicted that we would observe inhibition of FXR-dependent pathways in the distal ileum and perhaps the liver in Bt KO-colonized mice. We measured expression of FXR-dependent genes in these tissues using qPCR. Contrary to our expectations, we did not observe a significant difference in genes downstream of FXR, including *Nr0b2*/*Shp* (p=0.2018), *Fgf15* (p=0.6213), and *Fabp6*/*Ibabp* (p=0.6425), in the distal ileum ([Figure 9B](#fig9){ref-type="fig"}). We did observe a downregulation of *Nr0b2*/*Shp* and upregulation of *Cyp7a1* in the liver of Bt KO-colonized mice, results that are consistent with increased TβMCA-mediated FXR antagonism in Bt KO-colonized mice ([Figure 9C](#fig9){ref-type="fig"}). The total bile acid pool concentration in cecal contents was higher in Bt KO-colonized mice ([Figure 4A](#fig4){ref-type="fig"}), consistent with an increase in *Cyp7a1* transcription resulting in an increase in bile acid synthesis. We also observed decreases in the expression of other genes in the liver that are regulated by FXR, including *Apoc2*, which encodes a protein that is secreted into plasma and activates lipoprotein lipase, as well as increases in genes that are negatively regulated by the FXR target gene *Nr0b2*/*Shp*, including sterol regulatory element-binding protein 2 (*Srebf2/Srebp2*) and glucose-6-phosphatase (*G6pc*) ([Figure 9C](#fig9){ref-type="fig"}). While the former gene regulates cholesterol biosynthesis in the liver, the later gene catalyzes the final step in gluconeogenesis. The increase in *G6pc* in the liver of Bt KO-colonized mice is notable because this gene is significantly downregulated in the distal ilea of these mice ([Figure 8D](#fig8){ref-type="fig"}). Taken together, our data are consistent with a scenario in which bile-acid-mediated FXR antagonism is affecting pathways in the liver but not the ileum of Bt KO-colonized mice.

While some patterns of gene expression in the liver may be explained by FXR signaling, changes in the expression levels of certain notable pathways are not consistent with FXR-controlled regulation. We would expect to see an increase in the expression of the gene encoding sterol regulatory element binding protein 1 c (*Srebf1/Srebp1c*) as well as the downstream genes *Fas* and *Acc*, which are involved in de novo fatty acid synthesis, in the liver of Bt KO-colonized animals. No significant differences in expression of these genes, however, were observed between Bt KO- and WT-colonized mice (*Srebf1/Srebp1c*, p=0.5018; *Fas*, p=0.3292; *Acaca*, p=0.1302) ([Figure 9C](#fig9){ref-type="fig"}). In addition, we observed significant decreases in genes not known to be under the control of FXR, including *Cd36* (p=0.0015), a gene encoding a fatty acid transporter, the immune-related genes tumor necrosis factor alpha (Tnf/*Tnfα*, p=0.0225) and EGF-like module-containing mucin-like hormone receptor-like 1 (*Adgre1*/*Emr1*, p=0.0011), and the G-protein-coupled receptor S1pr2 target gene sphingosine kinase 2 (*Sphk2*, p=0.0274) ([@bib61]), in the liver of Bt KO-colonized mice ([Figure 9C](#fig9){ref-type="fig"}). These results indicate that other host receptors may be involved in the transcriptional changes and metabolic differences observed. Taken together, our data suggest that changing the in vivo bile acid pool using selective expression of a bacterial bile salt hydrolase results in significant alterations in host gene expression, and that these changes are due not to the detergent properties of bile acids but rather to their activities as signaling molecules.

Discussion {#s3}
==========

In this work, we identified a group of gut strains from the bacterial phylum Bacteroidetes that exhibit selective bile salt hydrolase activity. These bacteria selectively hydrolyze conjugated bile acid substrates based on the hydroxylation pattern of the steroidal core as opposed to the amino acid conjugate. Since the majority of BSH characterized to date from Bacteroidetes and Firmicutes are promiscuous and do not display selective deconjugation activity based on the bile acid substrate, it is possible that selective BSH activity may be an evolved trait. The lack of distinct clustering of Group I (i.e. steroidal core-selective) BSH at both the strain and protein levels suggests this activity that may have arisen multiple times in evolutionary history from different bacterial hydrolase precursors. Structural comparisons of closely related BSH with different selectivity profiles may reveal individual amino acids that could be responsible for the activities observed. It is also possible that differential trafficking of either the bile acid substrate or product or of the BSH protein itself ([@bib4]) in these Bacteroidetes strains may be responsible for some of the differences in reactivity. Additional microbiological, biochemical, and structural studies will be needed to answer these questions.

After identifying the gene responsible for BSH activity in *B. thetaiotaomicron* and generating a mutant (Bt KO), we leveraged these isogenic strains in order to manipulate the in vivo bile acid pool in a highly specific manner in monocolonized GF mice. Bt KO-colonized mice, which contained significantly higher cecal TβMCA levels than Bt wild type (WT)-colonized mice, gained less weight on a HFD, had lower liver and plasma lipid levels, and displayed a respiratory exchange ratio that was shifted toward lipid utilization. These changes in host metabolism are particularly striking in light of the fact that the only difference between these two groups of mice was the presence or absence of a single bacterial gene. Remarkably, the presence of this BSH gene in BT WT-colonized mice was able to recover the positive linear correlation between energy expenditure and lean body mass normally observed in both conventional mice and humans ([@bib23]; [@bib60]). This result suggests that specific genes in the gut microbiome may contribute to the establishment of host phenotypes not previously considered to be affected by the resident microbiota.

At a transcriptional level, genes related to metabolic pathways, circadian rhythm, immune modulation, and histone modifications were significantly altered in Bt KO- compared to Bt WT-colonized mice. Since TβMCA is a known FXR antagonist, we expected to observe changes in host gene expression that were consistent with downregulation of FXR-mediated pathways in Bt KO-colonized mice. The decreased expression of FXR target genes *Nr0b2*/*Shp* and *Apoc2* as well as the increased expression of *Cyp7a1*, the rate-limiting enzyme in bile acid biosynthesis, are consistent with a regime of FXR antagonism in the livers of Bt KO- compared to Bt WT-colonized mice. These transcriptional changes suggest that the observed increase in total bile acids in the cecal contents of Bt KO-colonized mice is due to FXR-dependent bile acid biosynthesis in the liver.

Other phenotypic and transcriptional differences observed between Bt KO- and Bt WT-colonized mice are not readily explained by FXR antagonism, however. Conventionally colonized FXR knockout (*Nr1h4^-/-^*) mice display less weight gain on a high-fat diet than wild-type mice ([@bib64]) and also have decreased liver expression of *Nr0b2*/*Shp* and increased expression of *Cyp7a1* ([@bib72]), consistent with our results in Bt KO-colonized mice. *Nr1h4^-/-^* mice, however, exhibit increased triglyceride and cholesterol levels in plasma ([@bib8]; [@bib45]; [@bib75]) and low blood glucose and delayed intestinal glucose absorption when fasted ([@bib8]; [@bib84]). Bt KO-colonized mice displayed the opposite phenotypes, including increased glucose and decreased triglyceride and cholesterol levels in plasma and a shift toward increased expression of glucose uptake and utilization genes in the distal ileum when fasted. While the expression of the FXR target genes *Nr0b2*/*Shp*, *Fgf15*, and *Fabp6*/*Ibabp* in the ileum are decreased in *Nr1h4^-/-^* mice ([@bib72]), we observed no transcriptional differences in these genes in Bt KO- and Bt WT-colonized mouse ilea. In addition, while the expression of hepatic gluconeogenesis genes is decreased in FXR-deficient mice ([@bib7]; [@bib18]; [@bib53]), we observed an increase in the expression of glucose-6-phosphatase (*G6pc*) in the liver of Bt KO-colonized mice. Taken together, these comparisons may indicate that many of the phenotypic and transcriptional differences noted in BT KO-colonized mice are either FXR-independent or not directly dependent on FXR-mediated signaling.

These results raise the possibility, then, that bile acid signaling through other host receptors may be in part responsible for the observed differences in host metabolism. Returning to the RNA-Seq data, we noted that there were significant differences in the expression of ileal genes involved in xenobiotic metabolism in Bt KO-colonized compared to BT WT-colonized mice. The pregnane X receptor (PXR) has been shown to play a central role in the response to xenobiotics, and in particular, in the transcriptional regulation of cytochrome P450 3A (*Cyp3A*) genes ([@bib5]). The expression of *Cyp3a11*, a mouse gene known to be regulated by PXR ([@bib40]), was significantly decreased (3.7-fold) in Bt KO-colonized animals. This result indicates that PXR-dependent pathways may be suppressed in these mice compared to Bt WT-colonized mice.

PXR also plays an important role in glucose and lipid homeostasis and energy metabolism ([@bib24]; [@bib41]; [@bib42]; [@bib62]). PXR knockout (*Nr1i2^-/-^*) mice gain less weight on a high-fat diet than wild-type mice and also display decreased liver steatosis and hepatic triglyeride levels ([@bib77]). Importantly, in contrast to FXR knockout (*Nr1h4^-/-^)* mice, *Nr1i2^-/-^* mice fed a high-fat diet exhibit increased fasting blood glucose levels and unchanged fasting insulin levels compared to wild-type mice ([@bib29]; [@bib77]). These metabolic phenotypes are consistent with those observed in Bt KO-colonized mice. Finally, PXR has been shown to be necessary and sufficient for the activation of the fatty acid transport gene *Cd36* in the liver ([@bib88]), and we observed a decrease in hepatic *Cd36* expression in BT KO-colonized mice. Taken together, our data are consistent with a regime of reduced PXR activation in Bt KO-colonized mice and perhaps suggest that PXR signaling may be involved in some of the metabolic phenotypes observed.

We cannot rule out the possibility that host receptors beyond FXR and PXR may be involved in the differences noted between Bt KO- and Bt WT-colonized mice. Exploration of bile acids as modulators of host metabolic, circadian rhythm, and immune response via binding to nuclear receptors and GPCRs is an experimental trajectory that warrants further investigation. Moreover, although our results support the conclusion that the observed changes in host metabolism are mediated by signaling properties of bile acids and not by their detergent activities, it is not yet clear which gene-level changes are driving the organism-level metabolic effects. Although our biochemical, transcriptional, and CLAMS data are consistent with a regime of decreased food intake in Bt KO- compared to Bt WT-colonized mice, we did not observe significant differences in plasma levels of leptin (p=0.4648, Bt WT vs Bt KO) and ghrelin (p=0.7783, Bt WT vs Bt KO), hormones regulating satiety and hunger ([Figure 8C](#fig8){ref-type="fig"}). Additional studies are needed to explore the contributions of bile acid signaling to host energy expenditure and feeding behavior.

Finally, because mice and humans possess different primary bile acids, there is the question of whether the observed changes in both bile acid composition and host metabolism are relevant for humans. While the major primary bile acids in mice are TβMCA and TCA ([@bib72]), humans produce glyco- and tauro-conjugated CDCA and CA ([@bib71]). Our in vitro results show that selective *Bacteroides* strains cleave conjugated C12 = H (e.g. βMCA, CDCA) but not C12 = OH (e.g. CA) primary bile acids. Based on our in vivo results, one would predict that these strains would cleave conjugated CDCA while leaving conjugated CA untouched in the human gut. Furthermore, analysis of data from the first and second phases of the Human Microbiome Project has revealed that the composition of the human gut community, specifically species of Bacteroidetes, is highly personalized. While Firmicutes were more temporally variable within individuals, Bacteroidetes species, and in particular the *Bacteroides* genus, displayed mainly inter-individual variation ([@bib44]; [@bib51]). Our results suggest that *Bacteroides* species status in individuals may in part determine downstream bile acid pool composition in these people. Finally, the FXR pathway as well as other host receptor pathways that may act as bile acid targets are highly conserved in mammals ([@bib66]), suggesting that discoveries about fundamental host signaling in mice are also likely to be operable in humans. Future studies in mice with humanized bile acid pools may reveal how selective *Bacteroides* BSH activity is likely to affect metabolism in the human host.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\            Designation                       Source or reference   Identifiers   Additional information
  or resource                                                                                              
  ---------------------------------- --------------------------------- --------------------- ------------- ---------------------------------
  Strain, strain background\         VPI 5482 \[CIP 104206T,\          ATCC                  ATCC 29148    
  (*Bacteroides thetaiotaomicron*)   E50, NCTC 10582\]                                                     

  Strain, strain background\         VPI 3452A\                        ATCC                  ATCC 43185    
  (*Bacteroides caccae*)             \[CIP 104201T, JCM 9498\]                                             

  Strain, strain background\         \[NCTC 11153\]                    ATCC                  ATCC 8483     
  (*Bacteroides ovatus*)                                                                                   

  Strain, strain background\         \[NCTC 11154\]                    ATCC                  ATCC 8482     
  (*Bacteroides vulgatus*)                                                                                 

  Strain, strain background\         Not applicable                    ATCC                  ATCC 8492     
  (*Bacteroides uniformis*)                                                                                

  Strain, strain background\         \[NCTC 11152\]                    ATCC                  ATCC 8503     
  (*Parabacteroides distasonis*)                                                                           

  Strain, strain background\         VPI 2553\                         ATCC                  ATCC 25285    
  (*Bacteroides fragilis*)           \[EN-2; NCTC 9343\]                                                   

  Strain, strain background\         VPI T4-1\                         ATCC                  ATCC 43184    
  (*Parabacteroides merdae*)         \[CIP 104202T, JCM 9497\]                                             

  Strain, strain background\         Not applicable                    DSMZ                  DSM-20697     
  (*Bacteroides eggerthii*)                                                                                

  Strain, strain background\         199                               DSMZ                  DSM-17565     
  (*Bacteroides finegoldii*)                                                                               

  Strain, strain background\         175                               DSMZ                  DSM-17855     
  (*Bacteroides dorei*)                                                                                    

  Strain, strain background\         5_1\_36/D4                        BEI                   HM-29         
  (*Bacteroides dorei*)                                                                                    

  Strain, strain background\         1_1\_6                            BEI                   HM-23         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         9_1\_42FAA                        BEI                   HM-27         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         D2                                BEI                   HM-28         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         3_1\_19                           BEI                   HM-19         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         2_1\_16                           BEI                   HM-58         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         20_3 (Deposited as\               BEI                   HM-166        
  (*Parabacteroides* sp.)            *Bacteroides* sp., Strain 20_3)                                       

  Strain, strain background\         2_1\_22                           BEI                   HM-18         
  (*Bacteroides* sp.)                                                                                      

  Strain, strain background\         638R                              Other                               Gift from Seth\
  (*Bacteroides fragilis*)                                                                                 Rakoff-Nahoum, Boston\
                                                                                                           Children\'s Hospital

  Strain, strain background\         NCIMB 8826\                       ATCC                  BAA-793       
  (*Lactobacillus plantarum*)        \[Hayward 3A, WCFS1\]                                                 

  Strain, strain background\         NCTC 8237 \[ATCC 19408,\          ATCC                  ATCC 13124    
  (*Clostridium perfringens*)        CIP 103 409, CN 1491,\                                                
                                     NCIB 6125, NCTC 6125, S 107\]                                         

  Strain, strain background\         *E. coli* S17-1 λ pir             Other                               Gift from Michael Fischbach,\
  (*Escherichia coli* S17-1 λ pir)                                                                         Stanford University

  Strain, strain background\         Bt WT                             Other                               Gift from Michael Fischbach,\
  (*B. thetaiotaomicron*\                                                                                  Stanford University
  VPI-5482 Δtdk)                                                                                           

  Strain, strain background\         BtΔ2086                           This paper                          See Materials and methods,\
  (*B. thetaiotaomicron*\                                                                                  'Construction of *Bacteroides*\
  VPI-5482 ΔtdkΔ2086)                                                                                      *thetaiotaomicron*\
                                                                                                           knockout mutants'

  Strain, strain background\         BtΔ1259                           This paper                          See Materials and methods,\
  (*B. thetaiotaomicron*\                                                                                  'Construction of *Bacteroides*\
  VPI-5482 ΔtdkΔ1259)                                                                                      *thetaiotaomicron*\
                                                                                                           knockout mutants'

  Strain, strain background\         BtΔ2086,2086+                     This paper                          See Materials and methods,\
  (*B. thetaiotaomicron*\                                                                                  'Construction of *Bacteroides*\
  VPI-5482 Δtdk Δ2086\                                                                                     *thetaiotaomicron*\
  pNBU2_erm_us1311_BT2086)                                                                                 complementation strains'

  Strain, strain background\         BtΔ2086,CTRL+                     This paper                          See Materials and methods, '\
  (*B. thetaiotaomicron*\                                                                                  Construction of *Bacteroides*\
  VPI-5482 Δtdk Δ2086\                                                                                     *thetaiotaomicron*\
  pNBU2_erm_us1311_CTRL)                                                                                   complementation strains'

  Recombinant DNA reagent            pExchange-tdk\                    PMID: 18611383                      
                                     (plasmid)                                                             

  Recombinant DNA reagent            pNBU2_erm_us1311\                 PMID: 25574022                      
                                     (plasmid)                                                             

  Sequence-based\                    BT2086_UF                         Eurofins Genomics                   GAA AGA AGA TAA CAT TCG AGT\
  reagent (knockout primer pairs)                                                                          CGA CAT CCA AAC CCA GTG\
                                                                                                           TGA ACT

  Sequence-based\                    BT2086_UR                         Eurofins Genomics                   CAT ATT ACT TCC AAA TTA AAT\
  reagent (knockout primer pairs)                                                                          AGT TGA TAC TC

  Sequence-based\                    BT2086_DF                         Eurofins Genomics                   GAG TAT CAA CTA TTT AAT TTG\
  reagent (knockout primer pairs)                                                                          GAA GTA ATA TGT AGT CGA TAG\
                                                                                                           TTA GTT ATG TGG TAA G

  Sequence-based\                    BT2086_DR                         Eurofins Genomics                   CCA CCG CGG TGG CGG CCG\
  reagent (knockout primer pairs)                                                                          CTC TAG AAG CAG ACG TTA TCC\
                                                                                                           TGG TTT C

  Sequence-based\                    BT1259_UF                         Eurofins Genomics                   GAA AGA AGA TAA CAT TCG AGT\
  reagent\                                                                                                 CGA CGG ATG ATT ATT GCC CCA\
  (knockout primer pairs)                                                                                  TTT TG

  Sequence-based\                    BT1259_UR                         Eurofins Genomics                   CGT ACA CAT AAT TTC GAT TTT\
  reagent\                                                                                                 TAG TTA TAG
  (knockout primer pairs)                                                                                  

  Sequence-based\                    BT1259_DF                         Eurofins Genomics                   CTA TAA CTA AAA ATC GAA ATT\
  reagent\                                                                                                 ATG TGT ACG TAA ATT GAT AGC\
  (knockout primer pairs)                                                                                  AGC TTG CTG C

  Sequence-based\                    BT1259_DR                         Eurofins Genomics                   CCA CCG CGG TGG CGG CCG\
  reagent\                                                                                                 CTC TAG ACG TTT TTC TAC CGG\
  (knockout primer pairs)                                                                                  ACG AAT C

  Sequence-based\                    us1311-BT-For-NdeI                Eurofins Genomics                   GGG TCC ATA TGA AGA AAA AAC\
  reagent (complementation\                                                                                TTA CGG GTG TTG C
  primer pairs)                                                                                            

  Sequence-based reagent\            BT-Rev-XbaI                       Eurofins Genomics                   CTA GTC TAG ACT ACA TCA CCG\
  (complementation\                                                                                        GAG TTT CGA A
  primer pairs)                                                                                            

  Sequence-based\                    pExchange_seq_UF                  Eurofins Genomics                   CGG TGA TCT GGC ATC TTT CT
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    pExchange_seq_DR                  Eurofins Genomics                   AAC GCA CTG AGA AGC CCT TA
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    BT2086_seq_F1                     Eurofins Genomics                   CAA CTG TCC GGG TGA ATA TAA AG
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    BT2086_seq_F2                     Eurofins Genomics                   GAA GTT TTC GTT GGG TGA ATG
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    BT1259_seq_F1                     Eurofins Genomics                   AGA AGG TAC ATC GCC TGT AC
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    BT1259_seq_F2                     Eurofins Genomics                   TAC TAT TCA CGC ACC ACA CC
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    pNBU2_UNIV-F                      Eurofins Genomics                   TAA CGG TTG TGG ACA ACA AG
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    pNBU2_UNIV-R                      Eurofins Genomics                   CAC AAT ATG AGC AAC AAG GAA TCC
  reagent (diagnostic primer)                                                                              

  Sequence-based\                    qBTBSH_F                          Eurofins Genomics                   GCGTGCGGGACACAATAAAG
  reagent (qRT-PCR primer)                                                                                 

  Sequence-based\                    qBTBSH_R                          Eurofins Genomics                   TAGCCTGTTGCGATTACGCT
  reagent (qRT-PCR primer)                                                                                 

  Sequence-based\                    qBT16s_F                          Eurofins Genomics                   GTGAGGTAACGGCTCACCAA
  reagent (qRT-PCR primer)                                                                                 

  Sequence-based\                    qBT16s_R                          Eurofins Genomics                   CTGCCTCCCGTAGGAGTTTG
  reagent (qRT-PCR primer)                                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------

Reagents {#s4-1}
--------

Conjugated and unconjugated bile acids were purchased from Steraloids Inc. (Newport, RI). Oleic acid, sodium oleate and 1-oleoyl-*rac*-glycerol were purchased from Sigma Aldrich.

Bacterial culturing {#s4-2}
-------------------

All Bacteroidetes strains were cultured at 37°C in brain heart infusion agar (Bacto) supplemented with with 5 mg/L hemin, 2.5 uL/L Vitamin K, and 500 mg/L cysteine HCl (BHI+). All strains were cultured under anaerobic conditions using an anaerobic chamber (Coy Laboratory Products) with a gas mix of 5% hydrogen and 20% carbon dioxide (balance nitrogen). *Escherichia coli* strains were grown aerobically at 37˚C in LB medium supplemented with ampicillin to select for the pExchange-tdk plasmid.

Bioinformatic search for candidate BSH in *B. thetaiotaomicron* {#s4-3}
---------------------------------------------------------------

A BLASTP search was performed on Integrated Microbial Genomes, the US Department of Energy's Joint Genome Institute (IMG JGI) using the bile salt hydrolase from *C. perfringens* (NCBI Protein accession code WP_003461725) as the query sequence, with a cutoff expectation value of 1 × 10^−5^.

Construction of *B. thetaiotaomicron* knockout mutants {#s4-4}
------------------------------------------------------

Plasmids and primers are listed in the Key Resources Table. All mutants were created in the *B. thetaiotaomicron* VPI-5482 Δ*tdk* background. The *BtΔ2086 and BtΔ1259* mutants were constructed using a previously described counterselectable allelic exchange method ([@bib43]). Briefly, \~1 kb fragments upstream and downstream of the BT2086 and BT1259 genes were cloned and fused using primer pairs (BT2086KO UF/UR and DF/DR; BT1259KO UF/UR and DF/DR) and ligated into the suicide vector pExchange-*tdk*. The resulting vectors were electroporated into *Escherichia coli* S17-1 λ *pir* and then conjugated into *B. thetaiotaomicron.* Single-crossover integrants were selected on BHI-blood agar plates containing 200 μg/ml gentamicin and 25 μg/mL erythromycin, cultured in TYG medium overnight, and then plated onto BHI-blood agar plates containing 200 μg/ml 5-fluoro-2-deoxyuridine (FUdR). Candidate BT2086 and BT1259 deletions were screened by PCR using the diagnostic primers listed in the Key Resources Table and confirmed by DNA sequencing to identify isolates that had lost the gene.

Construction of *B. thetaiotaomicron* complementation strains {#s4-5}
-------------------------------------------------------------

The *B. thetaiotaomicron* complementation strains were constructed using a previously described method with slight modifications. Assembled construct designs were based on the mobilizable *Bacteroides* element NBU2 ([@bib86]). Briefly, BT2086 was PCR-amplified, cloned as an NdeI/XbaI fragment into the constitutive expression vector *pNBU2_erm_us1311*, which contains the 300 bp region upstream of BT1311 (σ70), and transformed into *E. coli* S17-1 λ pir chemically competent cells ([@bib10]; [@bib14]). *E. coli* S17 lambda pir containing the desired plasmid or the *pNBU2_erm_us1311* control vector were cultured aerobically in 5 mL of LB media at 37°C, and the *Bacteroides* recipient strain (BtΔ2086) was cultured anaerobically in 5 mL BHI+ media at 37°C. The *E. coli* S17 donor strains and *B. theta* recipient strain were then subcultured in 5 mL of fresh media. At mid to late log growth, the transformed S17-1 cells were spun down, resuspended with *Bacteroides* strain (BtΔ2086) culture in 1 mL BHI+ media, spreaded on to a BHI+ 10% horse blood agar plate, and incubated aerobically at 37°C agar side down. After 16--24 hr, bacterial biomass from the conjugation plates was scraped and resuspended in 5 mL of BHI+ media and spread on to a BHI-blood agar plate containing 200 μg/mL gentamycin and 25 μg/mL erythromycin. Colonies were confirmed via PCR and sequencing using the diagnostic primers listed in the Key Resources Table. Recovery of function of the complementation strain was confirmed via UPLC-MS with 100 μM TUDCA as substrate.

Phylogenetic analysis of candidate BSHs and Bacteroidetes strains {#s4-6}
-----------------------------------------------------------------

BLASTP searches were performed on Integrated Microbial Genomes (IMG JGI) using BT2086 as the query sequence, with a cutoff expectation value of 1 × 10^−5^. Putative Bacteroidetes BSHs were identified from 19 of the 20 Bacteroidetes strains tested. A multiple sequence alignment was calculated using MUSCLE ([@bib19]). A phylogenetic tree was then computed from this alignment using PhyML ([@bib27]), choosing the LG substitution model, the SPR and NII (best) tree improvement method, 10 random starting trees, and bootstrap with 1000 replicas. The phylogenetic tree was visualized using iTOL ([@bib46]). A phylogenetic analysis of 20 Bacteroidetes strains was performed using PhyloPhlAn ([@bib73]). All 20 fully or partial sequenced microbial genomes were retrieved from IMG and the National Center for Biotechnology Information (NCBI).

In vitro assays for bile acid deconjugation by Bacteroidetes {#s4-7}
------------------------------------------------------------

All strains were cultured in 4 mL of BHI+ medium overnight. The following day they were diluted to pre-log phase (OD~600~ = 0.1) in fresh BHI+ to a final volume of 4 mL. Stock solution of taurine conjugated bile acids (TCA, TDCA, TCDCA, TUDCA, TLCA and TβMCA) or glycine conjugated bile acids (GCA, GDCA, GCDCA, GUDCA and GLCA) were added to each culture to obtain a final concentration of 50 µM of each bile acid. Cultures were then incubated in the anaerobic chamber at 37°C for 48 hr. At the 24 hr and 48 hr time points, 2 mL of each culture was extracted via the method described under 'Bile Acid Analysis - Sample Preparation for Bacterial Culture'.

Gnotobiotic mouse experiments {#s4-8}
-----------------------------

Germ-free C57BL/6 mice were maintained in gnotobiotic isolators at the Massachusetts Host-Microbiome Center under a strict 12 hr light cycle and a constant temperature (21 ± 1°C) and humidity (55--65%). All experiments were conducted on 8--9 week old male mice. GF status prior to the gavage was confirmed on a bi-weekly basis microbiologically through culturing mouse stool on broad-spectrum plates in both aerobic and anaerobic conditions, as well as Gram staining homogenized mouse stool in 1xPBS. TSA Blood Agar plates were used for aerobic conditions, while Brucella Blood Agar plates were used for anaerobic conditions. Monocolonization or GF status following gavage was confirmed by plating of fecal pellets (described below) and by 16S rRNA gene PCR and 16S sequencing. All experiments involving mice were performed using IACUC approved protocols under Brigham and Women's Hospital Center for Comparative Medicine.

For the monocolonization experiment, 12 weight-matched mice per group were colonized with either *B. thetaiotaomicron* wild type (Bt WT) or the Δ2086 mutant (Bt KO) by oral gavage of overnight cultures as previously described ([@bib55]). Frozen feces (day 2 post-colonization) were plated to determine CFU/g. The mice were co-housed in their respective groups in gnotobiotic isolators for the entire duration of the experiment. The mice were fed a standard diet containing 24% of calories from fat, 23% from protein, and 53% from carbohydrates (Autoclavable Mouse Breeder Diet 5021; LabDiet) for the first 4 days after gavage. After a 4-day acclimation period post-gavage, the mice were switched to a high-fat diet (Research Diets D12492) with 60 kcal% of fat sterilized by 10--20 kGy of gamma-irradiation. Mouse feces were collected 2 days after colonization to check bacterial colonization efficiency. This was achieved by homogenizing 1--2 fecal pellets in 1 mL PBS and then plating out 1:10 serial dilutions of the homogenate on BHI+ agar plates in the anaerobic chamber. BSH enzyme activities in different experimental groups were also checked via UPLC-MS for validation purposes. Fecal samples were collected on days 2, 4, 11, 18, 25 and 32 post-colonization and frozen at −80˚C prior to analysis. Mice were fasted for 4 hr prior to sacrifice, at which point tissues and blood were collected.

For the CLAMS experiment, GF mice were colonized as above with a third group of age- and weight-matched GF mice used as an additional control group (eight mice per group). Fresh feces (day 2 post-colonization) were plated to determine CFU/g. On day 24 and day 25 post-colonization, mice were transported in pre-sterilized CLAMS cages to Brigham and Women's Hospital (BWH) Metabolic Core facility to conduct metabolic studies. Animals were housed individually in metabolic chambers maintained at 22˚C under a 12 hr light/dark cycle with a constant access to food and water and maintained on a high-fat diet (Research Diets D12492). One mouse from the Bt WT-colonized group was excluded from the study because this animal refused food, lost 35% of its initial body weight in the CLAMS, and displayed GI tract abnormalities during sacrifice. Whole body metabolic rate was measured using the Oxymax open-circuit indirect calorimeter, Comprehensive Lab Animal Monitoring System (CLAMS, Columbus Instruments). Body composition was examined with Echo MRI (Echo Medical Systems, Houston, Texas) using the 3-in-1 Echo MRI Composition Analyzer ([@bib37]; [@bib58]), and respiratory exchange ratio (RER), calorific value (CV), and energy expenditure (EE) are calculated by the equations below:$$RER = \frac{VCO_{2}}{VO_{2}}$$$$CV\, = \, 3.815\, + \, 1.232 \ast RER$$$$EE\, = \, CV \ast VO_{2}$$

During sacrifice, whole blood was collected into commercially available EDTA-coated tubes (Milian Dutscher group). Cells were removed from plasma by centrifugation for 15 min at 2,000 g at 4°C. Plasma was transferred to a new eppendorf tube from the supernatant and stored in −80°C for further investigation. Cecal contents were collected at sacrifice (day 32) using sterile tools on a sterile field and plated to confirm maintenance of monocolonized or GF status throughout the experiment. No CFU were detected in the GF group. RNA extracted from these cecal contents was used for qRT-PCR using 16 s rRNA and *Bt BSH* primers (Key Resources Table, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

Plasma insulin, glucose and ghrelin levels were analyzed by the Vanderbilt Mouse Metabolic Phenotyping Center. Plasma glucose was measured by a glucose oxidase method using an Analox Instruments GM9 glucose analyzer (Stourbridge, UK). Plasma insulin was measured by radioimmunoassay (Millipore). Total ghrelin was measured by radioimmunoassay (Millipore). Plasma leptin, glucagon levels were analyzed by ELISA kits (Crystal Chem). Total plasma cholesterol, triglyceride and free fatty acids (FFA) were measured by standard enzymatic assays, and liver tissues were extracted ([@bib22]) and analyzed by the Vanderbilt University Metabolic Phenotyping Center (VUMC) using GC.

Bile acid analysis {#s4-9}
------------------

### Reagents {#s4-9-1}

Stock solutions of all bile acids were prepared by dissolving compounds in molecular biology grade DMSO (Sigma Aldrich). These solutions were also used to establish standard curves. GCA and βMCA or GCDCA were used as the internal standard for GF mouse experiments and in vitro bacterial culture (for glyco-conjugated or tauro-conjugated bile acid), respectively. Solvents used for preparing UPLC samples were HPLC grade.

### Sample Preparation for Bacterial Culture {#s4-9-2}

For extraction of bile acids, 2 mL of a bacterial culture was acidified to pH = 1 using 6N HCl. The culture was then extracted twice using 2 mL of ethyl acetate. In case of an emulsion, the biphasic solution was centrifuged at 2,500 g for 3 min to obtain a clear separation. The combined organic extracts were then dried over a Na~2~SO~4~ cotton plug, air dried, and reconstituted in 50% MeOH in dH~2~O for UPLC-MS analysis.

### Sample Preparation for Serum and Tissues {#s4-9-3}

Bile acids from serum and tissues that were collected from GF mouse experiments were extracted using the method of Sayin *et. al* with the following modifications ([@bib72]). Serum was transferred to a 1.5 mL eppendorf tube. 100 µL of bile acid standard with 1 µM GCA (internal standard) dissolved in MeOH was added to the tube. After vortexing for 1 min, the sample was cooled to −20°C for 20 min. The sample was then centrifuged for 10 min at 15,000 g, and the supernatant (\~100 µL) was transferred to another 1.5 mL eppendorf tube containing 50 µL of 50% MeOH in dH~2~O. The sample was then centrifuged for another 10 min at 15,000 *g*, and 50 µL of the supernatant was transferred to a mass spec vial and injected onto the UPLC-MS. Dilutions were applied if the concentrations of certain bile acids were out of the maximum detection range of the standard curve.

Tissue samples (approximately 100 mg) were pre-weighed in homogenizing tubes (Precellys lysing kit tough micro-organism lysing VK05 tubes) with ceramic beads. 400 uL MeOH containing 10 uM internal std (GCA) was added and thereafter homogenized (5000 speed for 90 s\*2, 6500 speed for 60 s, sample kept on ice between two runs) and spun down for 20 min at 15,000 *g*. Of the supernatant, 200 µL was then transferred to a tube containing 200 µL of 50% Methanol in dH~2~O followed by centrifugation for an additional 5 min at 15,000 *g*. Of the supernatant, 50 µL was used transferred to a mass spec vial and injected onto the UPLC-MS. Dilutions were applied if the concentrations of certain bile acids were out of the maximum detection range of the standard curve. For quantifying bile acids, a mixture of bile acid standard pool was always carried out along with the experiment.

### UPLC-MS analysis {#s4-9-4}

UPLC-MS was performed using a published method ([@bib80]) with modifications outlined as follows. 1 µL of a 200 µM solution of extracted bile acids was injected onto a Phenomenex 1.7 µm, C18 100 Å, 100 × 21 mm LC colum at room temperature and was eluted using a 30 min gradient of 75% A to 100% B (A = water + 0.05% formic acid; B = acetone + 0.05% formic acid) at a flow rate of 0.350 mL/min. Samples were analyzed using an Agilent Technologies 1290 Infinity II UPLC system coupled online to an Agilent Technologies 6120 Quadrupole LC/MS spectrometer in negative electrospray mode with a scan range of 350--550 m/z (other mass spec settings: fragmentor - 250, gain - 3.00, threshold - 150, Step size - 0.10, speed (u/sec) - 743). Capillary voltage was 4500 V, drying gas temperature was 300°C, and drying gas flow was 3 L/min. Analytes were identified according to their mass and retention time. For quantification of the analytes, standard curves were obtained using known bile acids, and then each analyte was quantified based on the standard curve and normalized based on the internal standards. The limits of detection for individual bile acids are as follows: βMCA, 0.03 picomol/μL in serum or 0.1 picomol/mg wet mass in tissues; TβMCA, 0.01 picomol/μL, 0.04 picomol/mg wet mass; CA, 0.04 picomol/μL, 0.17 picomol/mg wet mass; TCA, 0.01 picomol/μL, 0.04 picomol/mg wet mass; UDCA, 0.04 picomol/μL, 0.16 picmol/mg wet mass; TUDCA, 0.01 picmol/μL, 0.04 picmol/mg wet mass; CDCA, 0.04 picmol/μL, 0.14 picomol/mg wet mass; TCDCA, 0.01 picomol/μL, 0.03 picomol/mg wet mass.

Liver histological analysis {#s4-10}
---------------------------

Histology of the liver samples for steatosis was performed using a reported method ([@bib65]) in the Harvard Rodent Histopathology Core. Briefly, a portion of liver sample was cut and formalin-fixed, trimmed, cassetted and embedded in paraffin and stained with hematoxylin and eosin. Liver histology was assessed for steatosis on blinded sections.

Fecal bomb calorimetry {#s4-11}
----------------------

To determine the remaining caloric content in the mouse feces, bomb calorimetry was carried out using the Parr Oxygen Bomb equipped with a Parr 6725 Semimicro Calorimeter module and aParr 6772 Calorimetric Thermometer module at the Brigham and Women's Hospital (BWH) Metabolic Core facility. Briefly, 30--100 mg of pooled fecal samples from the sample mice were dehydrated at 60˚C for 48 hr in a micro centrifuge tube. Calculated heats (cal/g) take into account diurnal variations in fecal output as well as any contaminants that had entered into the sample.

Detergent assay {#s4-12}
---------------

### Synthesis of the sodium salt of β-muricholic acid {#s4-12-1}

To a solution of β-muricholic acid (6.0 mg, 0.0147 mmol) in 1.47 mL of methanol:toluene (1:1), 1M sodium hydroxide solution (0.15 μL, 0.016) was added and the resulting mixture was heated to 60°C for 18 hr. The reaction mixture was then cooled to room temperature and concentrated using a rotovap. The mixture was azeotroped thrice using toluene to ensure removal of water and the residue was dried thoroughly before being used in the assay.

The detergent ability of bile acid pools was investigated using a modified fat solubility assay described by Hofmann and coworkers ([@bib30]; [@bib49]). Briefly, stock solutions of respective fats and bile acids of known concentrations were made by dissolving them in methanol. The fats were then mixed in 1:1:1 ratio in a 96-well plate to obtain the required final concentrations. Respective amounts of different bile acid stock solutions were then added to each of the wells to reconstitute the bile acid pool concentrations observed in vivo (Bt WT bile acid pool: 8.7 mM total, including 7.1 mM TβMCA; Bt KO bile acid pool: 14.0 mM total, including 11.9 mM TβMCA). For comparison, the detergent sodium dodecyl sulfate (SDS) was used as a positive control at its critical micellar concentration (8.2 mM). SDS was added as a solution in methanol to obtain the required final concentration. The plate was then dried overnight. The dried residue was then suspended in freshly prepared 0.15 M sodium phosphate at pH 6.3. In order to account for the slight difference in the concentration of Na^+^ ions arising from the difference in concentrations of the bile acids in the two pools, exogenous sodium chloride was added to maintain similar concentrations. The plate was then sealed and incubated at 37°C for 24 hr after which the absorbance was measured at 400 nm using a SpectraMax Plus 384 Microplate Reader spectrophotometer. At the lowest fat concentration (2 mM), this assay was performed in 1 mL of 0.15 M sodium phosphate in a 1 mL cuvette in order to obtain accurate OD~400~ measurements. The solutions of fats and detergents were prepared in a similar manner as described above.

Gene expression analysis {#s4-13}
------------------------

### RNA-Seq analysis {#s4-13-1}

Total RNA was extracted from frozen mouse distal ileum obtained from the monocolonization experiment using RNeasy Mini Kit (Qiagen) and DNA was removed by on-column DNase digestion using RNAse-free DNAse Set (Qiagen) (n = 6). RNA quality was checked on Bioanalyzer before proceeding to library preparation and RNA-sequencing (paired-end, 100 bp read length) on Illumina HiSeq 2500 platform by the Biopolymers Facility at Harvard Medical School. Illumina\'s Ribo Zero H/M/R kit was used to perform ribosomal reduction. Agilent Tapestation 4200 was used for post-prep QC with the High Sensitivity D1000 assay. The data from the Tapestation assay was combined with the data from KAPA library quantification qPCR on the Applied Biosystems QuantStudio seven instrument. The libraries were pooled equimolar and were sequenced on the HiSeq 2500 at 8.0pM with 5% PhiX.

Reads were assessed for quality using FastQC and aggregated in MultiQC (Cambridge, UK: Babraham Institute, 2011, n.d.; [@bib20]). STAR aligner was used against mouse geneome GRCm38 revision 91 ([@bib16]). The edgeR package was performed for the differential expression analysis, using the exacTest calculation and Benjamini-Hochberg correction (FDR) ([@bib57]; [@bib69]). FDR ≤ 0.05, fold-change (FC) ≥±1.5 were set as the threshold. The goseq package was used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, with significant differentially expressed genes subjected to a probability weighting function and gene length bias accounted ([@bib87]). RNA-Seq data are deposited in the Gene Expression Omnibus (GEO) database (accession GSE112571).

### qRT-PCR {#s4-13-2}

Total RNA was extracted from liver and distal ileum tissues obtained from mice from the monocolonization experiment as previously described and reverse transcribed using a High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). The resultant cDNA was diluted and analyzed by qRT--PCR using LightCycler 480 SYBR Green I Master (Roche). Reactions were performed in a 384-well format using a LightCycler 480 System (Roche) at Harvard Medical School\'s ICCB-Longwood Screening Facility. The 2^-ΔΔCt^ method ([@bib50]) was used to calculate relative changes in gene expression and all results were normalized to the mouse ribosomal protein L32 mRNA.

Statistical analysis {#s4-14}
--------------------

Unless otherwise indicated in the figure legends, differences between experimental groups or conditions were evaluated using unpaired two-tailed Welch's t test for pairwise comparison, one-way ANOVA for multiple comparisons. Significance was determined as p value \< 0.05. Statistical analysis and plotting for metabolic studies was performed in the R programming language with CalR, a custom package for analysis of indirect calorimetry using analysis of covariance with a graphical user interface ([@bib58]).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A selective gut bacterial bile salt hydrolase alters host metabolism\" for consideration by *eLife*. Your article has been reviewed by Wendy Garrett as the Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Jason Ridlon (Reviewer \#2). The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

All three reviewers were very enthusiastic about this manuscript and are in principle supportive of its publication pending revision in the upcoming *eLife* microbiome special issue. In this report, Yao et al. screened *Bacteroides* spp. for bile salt hydrolysis activity against a panel of conjugated bile salts and decided on *B. thetaiotaomicron* which deconjugated TβMCA (FXR antagonist) but not TCA (FXR agonist). Since *B. theta* has a well-defined genetic system, the authors knocked out the gene encoding bile salt hydrolase (BSH). Finally, they performed studies of gnotobiotic mice mono-associated with wildtype *B. theta* or an isogenic mutant lacking a candidate BSH gene. The two colonization groups exhibited altered metabolism in many aspects, suggesting that the ability of gut microbes to carry out this activity could impact host biology. This model is a great starting point for a more detailed dissection of the role of specific bacterial genes and metabolites in diet-induced obesity.

Essential revisions:

While there are many potential areas for future study, the reviewers agreed that one major issue that is necessary to address prior to publication is that the authors do not complement any of their mutations. It is unclear whether the genetic deletions cause phenotypes due to the absence of the targeted gene, polar effects on other genes, or random mutations that occurred elsewhere in the genome during the genetic engineering process. While it could be argued that such events are unlikely, complementation is an important part of any bacterial genetic analysis.

Additional caveats can likely be addressed in the Discussion section without the need for more experiments. This includes the unclear relevance of these findings to humans. The focus is on a primary bile acid (TβMCA) that is unique to mice and mono-colonized mice are obviously an artificial system. The authors should include more discussion about why human gut bacteria would have evolved enzymes that target mouse bile acids; perhaps consistent with some degree of enzyme promiscuity. The in vivo mechanism of action remains unclear, necessitating future studies. The authors should comment on the degree to which these phenotypes may be dependent or independent of FXR and discuss alternative mechanisms of action. The authors should also include a more in-depth discussion of the identified *Bacteroides* BSH and the potential mechanism that determines its specificity. Are there any distinguishing characteristics of selective versus non-selective strains, either in terms of primary sequence, genetic neighborhood, or other factors?

The screen presented in Figure 2 is a major part of the paper but needs to be presented in more detail. It was not clear why 25% was used as the threshold instead of presenting the actual% conversion. No time curves are shown making it hard to evaluate if 48 hours represents steady state for these reactions. There are also no replicates shown making it impossible to determine the reproducibility of these results. It also seems important to test the full panel of compounds against the isogenic strains to enable a more definitive test of selectivity. This experiment should be done in replicate and include appropriate statistics (traces aren\'t sufficient). The authors should also address the major caveat that *B. theta* was actually a poor metabolizer of Tβ MCA in Figure 2A, which is the focus of all the subsequent experiments.

Finally, the manuscript needs a careful round of revisions. Multiple inconsistent results and non-significant \"trends\" can be trimmed down substantially. The host phenotype sections were particularly difficult to read and interpret due to the mixing of non-significant and significant results. It was also hard to keep track of which results were reproduced across both mouse experiments, which could be addressed by a supplemental table or summary diagram.

Reviewer \#1:

Yao et al. present an analysis of bile salt hydrolase activity by human gut *Bacteroides*. The major advance here is that unlike in other bacteria *Bacteroides* encode hydrolases selective for specific types of conjugated bile acids. They then go on to identify the gene responsible based on sequence homology to well-characterized enzymes, to confirm this gene by genetic deletion in *B. theta*, and to show that this gene is relevant in vivo using mono-association studies in gnotobiotic mice. This model is a great starting point for a more detailed dissection of the role of specific bacterial genes and metabolites in diet-induced obesity.

A major limitation to the study, as mentioned by the authors in their discussion, is the unclear relevance of these findings to humans. The focus is on a primary bile acid (TβMCA) that is unique to mice and mono-colonized mice are obviously an artificial system. The latter might be addressed by colonizing mice with a defined gut microbiota or introducing these genetically engineered strains to SPF animals. I think it\'s also important to discuss why human gut bacteria would have evolved enzymes that target mouse bile acids; perhaps consistent with some degree of enzyme promiscuity.

I also would have liked to see a more in-depth analysis of the identified *Bacteroides* BSH and the potential mechanism that determines its specificity. Are there any distinguishing characteristics of selective versus non-selective strains, either in terms of primary sequence, genetic neighborhood, or other factors? One way to get at this would be to express both types of genes in the same host to determine if this selectivity is intrinsic to the gene itself or depends on the background genetic context.

The screen presented in Figure 2 is a major part of the paper but could be presented in more detail and potentially multiple figures. It was not clear why 25% was used as the threshold instead of presenting the actual% conversion. No time curves are shown making it hard to evaluate if 48 hours represents steady state for these reactions. There are also no replicates shown making it impossible to determine the reproducibility of these results. It also seems important to test the full panel of compounds against the isogenic strains to enable a more definitive test of selectivity. This experiment should be done in replicate and include appropriate statistics (traces aren\'t sufficient).

The host phenotypic data was remarkable especially given the fact that only a single gene was altered (assuming no background mutations; see comment below). However, the mechanism of action gets pretty murky. The authors seem to rule out FXR, despite using it as a rationale for these experiments, raising the question of what the signaling pathway actually is. A couple of candidates are mentioned, but I\'m skeptical as to the ability to definitively implicate these pathways based only on the transcriptional profiling data. Experiments in transgenic mice would go a long way towards testing the role of FXR or other nuclear receptors.

I was also concerned about some inconsistent results throughout the paper and the inclusion of a lot of non-significant \"trends\". In my opinion, one cannot assign any meaning to trends for these types of metabolic experiments, especially without any independent replication experiments. It also made the host phenotype sections really difficult to read and interpret due to the mixing of non-significant and significant results. It was also hard to keep track of which results were reproduced across both mouse experiments. Another major caveat is that *B. theta* was actually a poor metabolizer of TβMCA in Figure 2A, which is the focus of all the subsequent experiments.

Reviewer \#2:

The manuscript by Yao et al., screened *Bacteroides* spp. for bile salt hydrolysis activity against a panel of conjugated bile salts and decided on *B. theta* which deconjugated TβMCA (FXR antagonist) but not TCA (FXR agonist). Since *B. theta* has a well-defined genetic system, the authors knocked out the gene encoding bile salt hydrolase (BSH). They then colonized germ-free C57BL/6 mice with WT vs. BSH KO vs. GF and determined that weight loss in the KO colonized mice was not due to differential colonization, nor differences in fecal caloric profile, nor differences in detergent properties of ileal bile acids between groups. This makes sense because it is likely that *B. theta* will colonize cecum, rather than ileum. Instead, the effects were due to signaling (FXR-dependent and FXR-independent) which may or may not be directly related to bile salt composition rather than say alterations in *B. theta* physiology upon loss of BSH activity. This is a well-executed study and well-written manuscript.

Reviewer \#3:

In this report, Yao et al., characterize the contribution of microbiome bile salt hydrolase activity through studies of gnotobiotic mice mono-associated with wildtype *Bacteroides thetaiotaomicron* or an isogenic mutant lacking a candidate BSH gene. The authors report that these mice exhibit altered metabolism in many aspects, suggesting that the ability of gut microbes to carry out this activity could impact host biology.

1\) The authors do not complement any of their mutations. It is unclear whether the genetic deletions cause phenotypes due to the absence of the targeted gene, polar effects on other genes, or random mutations that occurred elsewhere in the genome during the genetic engineering process. While it could be argued that such events are unlikely, complementation is an important part of microbial genetic analysis.

2\) The authors do not demonstrate that the BT2086 protein has BSH activity.

3\) The authors do not demonstrate that BT2086 is expressed in mice. Combined with the comments above, this makes it difficult to evaluate the conclusions of the paper.

4). In Figure 7B (global transcriptional analysis), the authors conclude that \"samples form distinct clusters based on colonization status\". It is unclear how the data proves this, as the samples do not show this clustering in the figure. Statistical support for this claim should be provided to demonstrate that the optimal number of clusters is two, and that these clusters separate samples based on colonization status.

10.7554/eLife.37182.026

Author response

> Summary:
>
> All three reviewers were very enthusiastic about this manuscript and are in principle supportive of its publication pending revision in the upcoming eLife microbiome special issue. In this report, Yao et al. screened Bacteroides spp. for bile salt hydrolysis activity against a panel of conjugated bile salts and decided on *B. thetaiotaomicron* which deconjugated TβMCA (FXR antagonist) but not TCA (FXR agonist). Since *B. theta* has a well-defined genetic system, the authors knocked out the gene encoding bile salt hydrolase (BSH). Finally, they performed studies of gnotobiotic mice mono-associated with wildtype *B. theta* or an isogenic mutant lacking a candidate BSH gene. The two colonization groups exhibited altered metabolism in many aspects, suggesting that the ability of gut microbes to carry out this activity could impact host biology. This model is a great starting point for a more detailed dissection of the role of specific bacterial genes and metabolites in diet-induced obesity.

We're so glad to hear that the reviewers were enthusiastic about this paper. We thank the reviewers for their time and careful reading of this manuscript and figures. Below please find the reviewers' comments and concerns addressed in a point-by-point fashion.

> Essential revisions:
>
> While there are many potential areas for future study, the reviewers agreed that one major issue that is necessary to address prior to publication is that the authors do not complement any of their mutations. It is unclear whether the genetic deletions cause phenotypes due to the absence of the targeted gene, polar effects on other genes, or random mutations that occurred elsewhere in the genome during the genetic engineering process. While it could be argued that such events are unlikely, complementation is an important part of any bacterial genetic analysis.

We agree with the reviewers that complementation to restore the wild-type profile of *Bacteroides thetaiotaomicron* would strengthen our finding that BT2086 is responsible for the bile salt hydrolase activity in this species. We did not originally perform this experiment as complementation is not standard practice for *B. theta*, perhaps due to the incomplete understanding of transcriptional and translation control in this organism (examples of papers where complementation was not performed for a *B. theta* knockout: Jacobson et al., 2018; Ng et al., 2013; Taketani et al., 2015.)

There are examples, however, in which *B. theta* has been successfully complemented (Cullen et al., 2015; Mishra and Imlay, 2013, Molec. Micriobiol.). Using the method of the Goodman and co-workers, we were able to successfully complement BT2086. We have added this result to Figure 2C and the figure legend: "Representative UPLC-MS traces showing that *Bacteroides thetaiotaomicron* wild-type (Bt WT) and BtΔ1259 deconjugate TUDCA whereas BtΔ2086 does not. BtΔ2086,2086^+^ recovered the deconjugation function while the BtΔ2086,CTRL^+^ control strain containing an empty pNBU2 vector did not, demonstrating that BT2086 is responsible for bile salt hydrolase activity in Bt."

We have also made the following changes to the main text and Materials and methods section:

Changed subsection heading from "BT2086 is a BSH in *Bacteroides thetaiotaomicron*" to "BT2086 is responsible for BSH activity in *Bacteroides thetaiotaomicron".*

Including the following in subsection "BT2086 is responsible for BSH activity in Bacteroides thetaiotaomicron": "Complementation of the Bt KO strain with BT2086 restored BSH activity (Figure 2C), confirming that BT2086 is necessary for bile acid deconjugation in Bt."

Including the following in subsection "Construction of *Bacteroides thetaiotaomicron* complementation strains": "The *Bacteroides thetaiotaomicron* complementation strains were constructed using a previously described method with slight modifications. \[...\] Recovery of function of the complementation strain was confirmed via UPLC-MS with 100 μM TUDCA as substrate."

> Additional caveats can likely be addressed in the Discussion section without the need for more experiments. This includes the unclear relevance of these findings to humans. The focus is on a primary bile acid (TβMCA) that is unique to mice and mono-colonized mice are obviously an artificial system. The authors should include more discussion about why human gut bacteria would have evolved enzymes that target mouse bile acids; perhaps consistent with some degree of enzyme promiscuity.

We appreciate the reviewers' suggestion to expand and clarify the sections of the text discussing the question of human relevance. In our interpretation, it is not that human gut bacteria have evolved enzymes to target mouse bile acids. Previously known gut bacterial BSH hydrolyze all conjugated bile acids (regardless of host source). Rather, the *Bacteroides* species uncovered here display some selectivity and this means that they can cleave C12=H but not C12=OH primary bile acids. Mice and humans both possess bile acids within the "cleaved" and "not cleaved" groups.

We have added the following text to the Discussion section to clarify this point and also further expand on the human relevance of our findings:

"Since the majority of BSH characterized to date from Bacteroidetes and Firmicutes are promiscuous and do not display selective deconjugation activity based on the bile acid substrate, it is possible that selective BSH activity may be an evolved trait. The lack of distinct clustering of Group I (i.e., steroidal core-selective) BSH at both the strain and protein levels suggests this activity that may have arisen multiple times in evolutionary history from different bacterial hydrolase precursors. Structural comparisons of closely related BSH with different selectivity profiles may reveal individual amino acids that could be responsible for the activities observed."

"While the major primary bile acids in mice are TβMCA and TCA (Sayin et al., 2013), humans produce glyco- and tauro-conjugated CDCA and CA (Russell, 2003). \[...\] Our results suggest that *Bacteroides* species status in individuals may in part determine downstream bile acid pool composition in these people."

> The in vivo mechanism of action remains unclear, necessitating future studies. The authors should comment on the degree to which these phenotypes may be dependent or independent of FXR and discuss alternative mechanisms of action.

We have expanded the Discussion section to include a more detailed explanation of the FXR-dependence or FXR-independence of the phenotypes observed. We have also expanded the discussion of alternative mechanisms:

"The decreased expression of FXR target genes *Shp* and *Apoc2* as well as the increased expression of *Cyp7a1*, the rate-limiting enzyme in bile acid biosynthesis, are consistent with a regime of FXR antagonism in the livers of Bt KO- compared to Bt WT-colonized mice. \[...\]

We cannot rule out the possibility that host receptors beyond FXR and PXR may be involved in the differences noted between Bt KO- and Bt WT-colonized mice."

In terms of which bile acids may be affecting PXR pathways, that remains an open question that we plan to tackle in subsequent research. The secondary bile acid lithocholic acid (LCA) is a PXR agonist (Staudinger et al., 2001). As expected, we did not detect LCA in any mice in our studies, as none of these mice were colonized with bacteria known to produce this molecule (Ridlon et al., 2006). It is possible, then, that bile acids that were found at significantly different levels between Bt KO-colonized and Bt WT-colonized mice may play a role in PXR regulation. The further exploration of bile acids as either ligands for PXR or molecules that affect pathways that regulate PXR activation falls outside the scope of the current work and will be addressed in a future paper.

> The authors should also include a more in-depth discussion of the identified Bacteroides BSH and the potential mechanism that determines its specificity. Are there any distinguishing characteristics of selective versus non-selective strains, either in terms of primary sequence, genetic neighborhood, or other factors?

In order to explore the question of the origin of selectivities observed in our 20-strain Bacteroidetes screen, we performed phylogenetic analyses at both the strain and protein levels. To help the reader follow our logic, we have now placed these 20 strains into 4 groups (now outlined in the Figure 2 legend): "Group I (red): Bacteroidetes species that deconjugate primary bile acids based on steroidal core structure (C12=H but not C12=OH); Group II (gray): species that deconjugate based on amino acid conjugate; Group III (blue): species that deconjugate all bile acid substrates; Group IV (black): no deconjugation observed." We then analyzed the phylogenetic clusterings of these 4 groups. We added a new Figure (now Figure 3) describing the results. The lack of clustering observed limits further interpretations at this time. However, as we suggest in our Discussion section, these phylogenetic trees reveal groups or pairs of BSH that could be subject to future structural analyses.

The subsection "Bacteroidetes BSH exhibit evolutionary diversity" was added to Results section.

The following was added to the Discussion section: "Since the majority of BSH characterized to date from Bacteroidetes and Firmicutes are promiscuous and do not display selective deconjugation activity based on the bile acid substrate, it is possible that selective BSH activity may be an evolved trait. \[...\] Structural comparisons of closely related BSH with different selectivity profiles may reveal individual amino acids that could be responsible for the activities observed."

The subsection "Phylogenetic analysis of candidate BSHs and Bacteroidetes strains" was added to Materials and methods section.

> The screen presented in Figure 2 is a major part of the paper but needs to be presented in more detail. It was not clear why 25% was used as the threshold instead of presenting the actual% conversion.

We initially presented the data in a crude heat map (no deconjugation, less than 25% deconjugation, more than 25% deconjugation) because our goal was to obtain a "yes/no" answer for whether a given Bacteroidetes strain deconjugated a given bile acid. Obtaining these "yes/no" answers for deconjugation abilities then allowed us to separate the 20 strains into groups based on their substrate preferences. We agree that adding more detail will make these heatmaps more useful to the reader. We now present the data as "full" heatmaps, with mean deconjugation values represented by colored shading (Figure 2A).

> No time curves are shown making it hard to evaluate if 48 hours represents steady state for these reactions.

We agree that it is important to discuss why we decided to plot our heatmaps at a 48 hour timepoint. By taking timepoints from bacteria from the different activity groups, we ascertained that all metabolism had ceased by 48 hours. We have added a new panel (now 2B) to Figure 2 showing representative timecourses from a Group I strain (*B. theta*) and a Group III strain (*Bacteroides* sp. 1_1\_6) to illustrate this finding. We have also added deconjugation heat maps from a 24 hour timepoint as a supplementary figure (Figure 2---figure supplement 3).

In addition, we made the following change to the main text (subsection "Selected species of *Bacteroides* accept distinct bile acid cores as BSH substrates"): "We monitored deconjugation over time by UPLC-MS and determined that all hydrolysis reactions had reached steady state by 48 hours (Figure 2B, Figure 2---figure supplement 3). We then quenched the cultures and profiled bacterial bile acid metabolism."

> There are also no replicates shown making it impossible to determine the reproducibility of these results. It also seems important to test the full panel of compounds against the isogenic strains to enable a more definitive test of selectivity. This experiment should be done in replicate and include appropriate statistics (traces aren\'t sufficient).

We included UPLC-MS traces in our initial submission because the use of representative traces is the standard way to represent data in the field of metabolite production by bacteria (examples: Yan et al., *eLife,* 2017. Figure 4B; Dodd et al., 2017. Figure 2D and H, Figure 3; Ganley et al., 2018. Figure 2.). We agree with the reviewers that it is important to show the reproducibility of these results. In our original Figure 2 legend, we specified that "Assays were performed in at least biological duplicate." We have replaced the Figure 2 supplements showing representative UPLC traces with graphs showing the% conversion of these biological duplicates. As stated in above, the goal of these experiments was to obtain a "yes/no" deconjugation answer for each strain for a given substrate. There were no instances where in one experiment, a strain did not deconjugate a bile acid at all and in the second experiment, deconjugation was detected (or vice versa). As such, a "tie-breaker" third experiment was not necessary.

We tested the full panel of bile acid substrates against the isogenic strains (BtΔ2086 and BtΔ1259) and have added these results to the bottom of the heatmaps as well as Figure 2---figure supplements 1, 2, and 3. As expected, BtΔ2086 did not deconjugate any of the bile acid substrates and BtΔ1259 displayed Bt WT deconjugation abilities.

> The authors should also address the major caveat that *B. theta* was actually a poor metabolizer of TβMCA in Figure 2A, which is the focus of all the subsequent experiments.

We have addressed this caveat and explained why we chose to focus on *B. theta* in the following text added to the Results section:

"All of the five Group I strains displayed weak to moderate deconjugation of TβMCA in vitro (Figure 2A).\[...\] Although this strain displayed relatively weak TβMCA-deconjugating activity, Bt had been previously shown to be amenable to genetic manipulation, allowing knockout of putative BSH genes (Cullen et al., 2015; Koropatkin, Martens, Gordon, and Smith, 2008)."

> Finally, the manuscript needs a careful round of revisions. Multiple inconsistent results and non-significant \"trends\" can be trimmed down substantially. The host phenotype sections were particularly difficult to read and interpret due to the mixing of non-significant and significant results.

We have carefully revised the main text and corresponding figures in order to increase the clarity of this work and to cut down on the discussion of "trends." We have also added labels to our figure panels to aid the reader in switching from the main text to the figures and back again. Major changes are as follows:

Figure 1: Highlighted C12, the key site of recognition for the selective Bacteroides BSH; wrote out "deoxycholic acid" and "lithocholic acid".

Corresponding textual changes: Converted all references to R=H and R=OH to C12=H and C12=OH.

Figure 4 (was Figure 3): Added a schematic timeline for the monocolonization and CLAMS GF experiments (new A). Enlarged the bile acid bar graphs to make them easier to read. Moved liver and plasma bile acids to Figure 4---figure supplement 2.

Corresponding textual changes: Added references to Figure 4A to main text. Streamlined discussion of bile acid analyses and removed references to trends in cecal contents: "As we predicted, Bt KO-colonized mice displayed higher levels of TβMCA in cecal contents than Bt WT-colonized mice in the monocolonization experiment (Figure 4B). \[...\] We observed the same significant difference in βMCA levels in feces (Figure 4C, red highlight boxes)."

We are still including our discussion of trends in the distal ileum because we feel that we explain how biological differences may explain the variation in bile acid values observed.

Figure 5 (was Figure 4): In Figure 5B, converted CFU/g from a linear to a log scale and removed the GF condition from these plots. Added the words "plasma" and "liver" to Figure 5C and D, respectively, for a quick visual reference of tissue type for the lipid analyses.

Figure 6 (was Figure 5): Moved the locomotor activity panels to Figure 6---figure supplement 1. Switched the CO~2~ production and O~2~ consumption panels to correspond to the reworded main text.

Corresponding textual changes: Removed the discussion of trends in locomotor activity, clarified the CO~2~ / O~2~ discussion as related to RER:

(Subsection "Bt BSH status affects host metabolic indications") "While Bt KO-colonized mice consumed more oxygen than Bt WT-colonized mice (Figure 6B), there were no significant differences in carbon dioxide production between groups (full day, Bt WT vs Bt KO p=0.4041; Bt WT vs GF p=0.3239; Bt KO vs GF p=0.0606) (Figure 6C). These data are consistent with the lower RER observed in Bt KO-colonized mice. No statistically significant differences in locomotor activity were noted between the three groups (Figure 6---figure supplement 1)."

Figure 8 (was Figure 7): Enlarged the pictures and text in panels Figure 8A and B. Moved plasma glucose to new Figure 9 and rearranged Figure 8C and D (now panels C, D, and E). Split panel D into two panels (now D and E) based on the biological functions of the genes. Added labels to panels C (Distal ileum, RNA-Seq), D (Distal ileum, glucose and lipid metabolism gene expression), and E (Distal ileum, circadian rhythm gene expression). Removed results that were not statistically significant (i.e., *Slc2a1, Cry1, Cry2* gene expression).

Corresponding textual changes: Removed the reference to qPCR of *Slc2a1*.

Figure 9 (was Figure 8): Moved glucose, insulin, leptin, and ghrelin to panel A and added labels above each plot. Removed liver expression of FXR and circadian rhythm genes (most not statistically significant). Grouped liver genes into FXR-mediated and FXR-independent groups. Added not significant (ns) bars where relevant to clarify statistical outcomes. Added a p value to liver *Srebp2*. Added labels to panels B and C (Distal ileum, FXR-mediated gene expression; Liver, FXR-mediated gene expression and Liver, FXR-independent gene expression).

Corresponding textual changes: Changed the concluding sentence of the first paragraph in the Results section (subsection "Bile acid pools alter the expression of FXR-dependent and FXR-independent genes in the liver and distal ilem"): "Taken together, our data are consistent with a scenario in which bile acid-mediated FXR antagonism is affecting pathways in the liver but not the ileum of BT KO-colonized mice."

Clarified and shortened the paragraph discussing FXR-independent signaling in the Results (subsection "Bile acid pools alter the expression of FXR-dependent and FXR-independent genes in the liver and distal ileum"): "In addition, we observed significant decreases in genes not known to be under the control of FXR, including *Cd36* (p=0.0015), a gene encoding a fatty acid transporter, the immune-related genes tumor necrosis factor α (*Tnfα*, p=0.0225) and EGF-like module-containing mucin-like hormone receptor-like 1 (*Emr1*, p=0.0011), and the G-protein coupled receptor S1pr2 target gene sphingosine kinase 2 (*Sphk2*, p=0.0274) (Nagahashi et al., 2015), in the liver of Bt KO-colonized mice (Figure 9C). These results indicate that other host receptors may be involved in the transcriptional changes and metabolic differences observed."

> It was also hard to keep track of which results were reproduced across both mouse experiments, which could be addressed by a supplemental table or summary diagram.

(See above): We added a schematic timeline for the monocolonization and CLAMS GF experiments (new Figure 4A).

We also included a new table (Figure 4---table supplement 1) outlining which analyses were performed using which mouse experiment(s).

Reviewer 1 had also raised this point: *\[...\] The host phenotypic data was remarkable especially given the fact that only a single gene was altered (assuming no background mutations; see comment below). However, the mechanism of action gets pretty murky. The authors seem to rule out FXR, despite using it as a rationale for these experiments, raising the question of what the signaling pathway actually is. A couple candidates are mentioned, but I\'m skeptical as to the ability to definitively implicate these pathways based only on the transcriptional profiling data. Experiments in transgenic mice would go a long way towards testing the role of FXR or other nuclear receptors.*

We considered performing an experiment in germ-free FXR knockout mice but decided against it for two main reasons (one biological, the other technical). First, research has shown that on both normal chow and a high-fat diet, FXR KO mice gain significantly less weight than wild-type mice (Prawitt et al., 2011, Figure 5A). HFD-fed FXR KO mice also display lower glucose and insulin levels. The difference in phenotype of FXR KO mice monocolonized by Bt KO compared to Bt WT would likely be masked by this strong metabolic FXR KO phenotype, therefore eliminating the usefulness of performing this experiment. Second, there would be considerable cost, time, and expertise required to re-derive FXR KO mice germ-free and also to maintain a breeding colony of these FXR KO mice once they were GF. Based on these two factors, we decided against performing an experiment in GF FXR KO mice.

[^1]: Indigo Agriculture, Boston, United States.
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